hydroxychloroquine has been researched along with methotrexate in 400 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (2.50) | 18.7374 |
| 1990's | 65 (16.25) | 18.2507 |
| 2000's | 94 (23.50) | 29.6817 |
| 2010's | 172 (43.00) | 24.3611 |
| 2020's | 59 (14.75) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Callahan, LF; Marcum, SB; Pincus, T | 1 |
| Szefler, SJ | 1 |
| Doughty, RA; Rose, CD | 1 |
| Clough, JD; Reardon, EV | 1 |
| Bloch, DA; Fries, JF; Singh, G; Spitz, P; Williams, CA; Zatarain, E | 1 |
| Clough, JD; Wilke, WS | 1 |
| Gross, WL; Reinhold-Keller, E; Schnabel, A; Wolff, HH | 1 |
| Bahremand, M; Schumacher, HR | 1 |
| Cathey, MA; Hawley, DJ; Wolfe, F | 1 |
| Kremer, JM | 3 |
| Fries, JF; Furst, DE; Lenert, L; Singh, G | 1 |
| Furst, DE | 1 |
| Ehrenfeld, M; Kaplinsky, N; Langevitz, P; Pras, M | 1 |
| Clegg, DO; Ward, JR | 1 |
| Høyeraal, HM | 1 |
| Dugowson, CE; Gilliland, BC | 1 |
| Kovarsky, J | 1 |
| Dührsen, U; Kirch, W; Ohnhaus, EE | 1 |
| Burnham, TK; Fine, G; Lester, RS; Murray, K | 1 |
| Bickers, DR; Callen, JP; Hanno, R; Hawkins, C; Voorhees, JJ; Woo, TY | 1 |
| Culclasure, TF; Shea, RJ; Singleton, JD | 1 |
| Carotti, M; Cervini, C; Salaffi, F | 2 |
| Hill, JM; Tattersfield, AE | 1 |
| Emery, HM | 1 |
| Bijlsma, JW; Jacobs, JW; Schenk, Y; van der Heide, A | 1 |
| Adams, LB; King, LE; Olsen, NJ; Park, JH | 1 |
| Moss, RB | 1 |
| Meenan, RF; Prashker, MJ | 1 |
| van 't Hof, M; van de Putte, LB; van der Heijde, DM; van Riel, PL | 1 |
| Callahan, LF; Pincus, T | 1 |
| Brewer, EJ; Cassidy, JT; Giannini, EH; Kuzmina, N; Maximov, A; Shaikov, A | 1 |
| Anaya, JM; Combe, B; Didry, C; Gutierrez, M; Sany, J | 1 |
| Wilske, KR | 1 |
| Calabrese, LH; Sweeney, TJ; Wilke, WS | 1 |
| McCarty, DJ | 1 |
| Bloch, DA; Fries, JF; Ramey, D; Williams, CA | 1 |
| Trentham, DE | 1 |
| Spencer-Green, G | 1 |
| Anaya, JM; Combe, B; Guttierrez, M; Sany, J | 1 |
| Criswell, LA; Henke, CJ | 1 |
| Drymalski, W; Eckhoff, PJ; Erikson, N; Garwood, V; Haire, CE; Klassen, LW; Klein, H; Maloley, P; Moore, GF; O'Dell, JR; Palmer, W; Wees, S | 1 |
| Cameron, BJ; Laxer, RM; Muzaffer, MA; Schneider, R; Silverman, ED | 1 |
| Cohen, PR; Hymes, SR; Vine, JE; Warner, NB | 1 |
| Arkfeld, DG; Stohl, W | 1 |
| DeMarco, DM; Liu, NY; Zurier, RB | 1 |
| Khraishi, MM; Singh, G | 1 |
| Drymalski, W; Erikson, N; Haire, C; Klassen, LW; Maloley, P; Moore, GF; O'Dell, JR; Palmer, W; Wees, S | 1 |
| Spector, SL | 1 |
| Fries, JF; Ramey, DR; Singh, G; Williams, CA | 1 |
| Haagsma, CJ; van Riel, PL | 1 |
| Lee, CH; Lee, J; Lee, SK; Song, JH; Suh, JS; Yoon, M | 1 |
| Bell, CL; Clegg, DO; Dietz, F; Duffy, J; Germain, BF; Hurd, E; Sleckman, J; Wall, B; Wallace, DJ; Willkens, RF | 1 |
| Fantini, F; Gattinara, M; Gerloni, V; Lomater, G; Zeni, S | 1 |
| Cash, JM; Recht, M; Tyree, J | 1 |
| Wollenhaupt, J; Zeidler, H | 1 |
| Criswell, LA; Such, CL; Yelin, EH | 1 |
| Hannonen, PJ; Kautiainen, HJ; Sokka, TM | 1 |
| Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A; Pacor, ML; Zeminian, S | 1 |
| Giannini, EH; Moroldo, MB | 1 |
| McCune, WJ; Singer, NG | 1 |
| Drymalski, W; Eckhoff, PJ; Gaur, L; Gersuk, VH; Haire, C; Klassen, LW; Moore, GF; Nepom, BS; Nepom, GT; O'Dell, JR; Palmer, W; Thiele, G; Wees, S | 1 |
| O'Dell, JR | 1 |
| Altindağ, ZZ; Hasçelik, Z; Inanici, F; Sahin, G | 1 |
| Ahonen, J; Blåfield, H; Forsberg, S; Friman, C; Hakala, M; Hakola, M; Hannonen, P; Ilva, K; Järvinen, P; Julkunen, H; Kautiainen, H; Koota, K; Korpela, M; Laasonen, L; Leirisalo-Repo, M; Luukkainen, R; Möttönen, T; Nissilä, M; Paimela, L; Pälvimäki, I; Piirainen, H; Puolakka, K; Vuori, K; Yli-Kerttula, U | 1 |
| Klassen, LW; Moore, GF; O'Dell, JR | 1 |
| Choi, JH; Jang, KA; Koh, JK; Moon, KC; Sung, KJ; Yoo, B | 1 |
| Schattner, A | 1 |
| Battesti, JP; Brauner, M; Clerici, C; Lavergne, F; Sadoun, D; Valeyre, D | 1 |
| de Bandt, M | 1 |
| O'Dell, JR; Scott, DL | 1 |
| Mikuls, TR; O'Dell, J | 1 |
| Bijlsma, JW; Blaauw, AA; Brus, HL; Haanen, HC; Heurkens, AH; Hofman, DM; Jacobs, JW; Kruize, AA; Schenk, Y; ter Borg, EJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ; van Jaarsveld, CH | 1 |
| Hollister, JR | 1 |
| Bombardier, C; Maetzel, A; Strand, V; Tugwell, P; Wells, G; Wong, A | 1 |
| Bijlsma, JW; Blaauw, AA; Brus, HL; Jacobs, JW; Jahangier, ZN; Schenk, Y; ter Borg, EJ; van Albada-Kuipers, GA; van Der Veen, MJ; van Jaarsveld, CH | 1 |
| Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A; Pacor, ML | 1 |
| Balzamo, M; Ceccaldi, M; de Roux-Serratrice, C; Disdier, P; Donnet, A; Félician, O; Gaudy, C; Granel, B; Manera, L; Pache, X; Raybaud, C; Serratrice, J; Swiader, L; Weiller, PJ | 1 |
| Cho, CS; Kim, HY; Kim, WU; Lee, SK; Lee, WK; Paek, SI; Park, SH; Seo, YI; Song, HH | 1 |
| Allanore, Y; Kahan, A; Menkès, CJ; Perrot, S | 1 |
| Chang, DM; Han, SH; Ho, LJ; Lai, JH; Lu, KC; Shaio, MF | 1 |
| Capell, HA | 1 |
| O'Dell, J | 1 |
| Wasko, MC; Wildy, KS | 1 |
| Arlet, P; Carreiro, M; Lannes, F; Ollier, S; Sailler, L | 1 |
| Barthel, HR | 1 |
| Koler, RA; Montemarano, A | 1 |
| Pisetsky, DS; St Clair, EW | 1 |
| Allain, J; Berthelot, JM; Chalès, G; Devauchelle, V; Hoang, S; Le, GP; Le, HC; Martin, A; Nouy-Trolle, I; Saraux, A; Thorel, J; Youinou, P | 1 |
| Franzen, P; Gripenberg-Gahmberg, M; Hannonen, P; Helve, T; Ilonen, J; Kaipiainen-Seppänen, O; Kautiainen, H; Korpela, M; Koski, J; Laasonen, L; Leirisalo-Repo, M; Möttönen, T; Myllykangas-Luosujärvi, R; Nissilä, M | 1 |
| Scott, DL | 1 |
| Beaurain, D; Delcambre, B; Duquesnoy, B; Flipo, RM; Grardel, B; Marguerie, L | 1 |
| Erkan, D; Harrison, MJ; Paget, SA; Yazici, Y | 1 |
| Blakely, K; Churchill, M; Eckhoff, PJ; Felt, J; Fernandez, A; Hadley, S; Haire, C; Klassen, L; Leff, R; Mallek, J; Moore, G; O'Dell, JR; Palmer, W; Paulsen, G; Stoner, J; Waytz, P; Wees, S | 1 |
| Albert, DA; Fries, JF; Hurst, S; Kallan, MJ; Wolfe, FJ | 1 |
| Giannini, EH | 1 |
| Beal, J; Carmichael, SJ; Day, RO; Tett, SE | 1 |
| Jiang, L; Ni, L; Zhao, N | 1 |
| Kellner, H; Schiemann, U | 1 |
| Baranauskaite, A; Misiūniene, N | 1 |
| Gross, WL; Schnabel, A | 1 |
| Kaarela, K; Klaukka, T | 1 |
| Arlet, P; Astudillo, L; Carreiro, M; Dahan, S; Ollier, S; Sailler, L | 1 |
| Førre, Ø; Haga, HJ; Johnsen, V; Kvien, TK; Mikkelsen, K; Nordvåg, BY; Rødevand, E | 1 |
| Bijlsma, JW; Borg, EJ; Heurkens, AH; Hofman, DM; Jacobs, JW; van Booma-Frankfort, C; van der Veen, MJ; Verstappen, SM | 1 |
| Rau, R; Wassenberg, S | 1 |
| Alfieri, G; Atzeni, F; Beyene, NB; Cazzola, M; Chérié-Lignière, EL; Corbelli, V; D'Ingianna, E; Fiorentini, F; Fiorini, T; Fumagalli, M; Locati, M; Mastaglio, C; Menozzi, G; Monti, G; Panni, B; Saccardo, F; Sarzi-Puttini, P; Scarpellini, M; Severi, C | 1 |
| Conaghan, PG; Emery, P; Green, MJ; Karim, Z; Marzo-Ortega, H; Proudman, S; Quinn, MA; Wakefield, RJ | 1 |
| Bar-Din, M; Griffiths, RI; Herbert, RJ; MacLean, CH; Sullivan, EM; Yelin, EH | 1 |
| Carmichael, SJ; Charles, B; Tett, SE | 1 |
| Finesilver, AG | 1 |
| Blåfield, H; Hakala, M; Hannonen, P; Julkunen, H; Kautiainen, H; Korpela, M; Leirisalo-Repo, M; Luukkainen, R; Möttönen, T; Paimela, L; Puolakka, K; Vuori, K | 1 |
| Christianson, TJ; Fulbright, JW; Goronzy, JJ; Matteson, EL; McClelland, RL; Weyand, CM | 1 |
| Bijlsma, JW; Blaauw, AA; Haanen, HC; Jacobs, JW; Schenk, Y; van Albada-Kuipers, GA; Verstappen, SM | 1 |
| Weinblatt, ME | 1 |
| Apras, S; Calgüneri, M; Cobankara, V; Ertenli, I; Haznedaroglu, IC; Kiraz, S; Ozatli, D; Oztürk, MA; Türk, T | 1 |
| Cui, Y; Luo, rQ; Yao, RY; Zhang, X; Zhou, H | 1 |
| Ahn, MJ; Bae, SC; Choi, BR; Jun, JB; Kim, TH; Lee, WS | 1 |
| Emery, P; Suarez-Almazor, M | 1 |
| Issa, SN; Ruderman, EM | 1 |
| Ahonen, J; Forsberg, S; Hakala, M; Hannonen, P; Järvinen, P; Kautiainen, H; Korpela, M; Leirisalo-Repo, M; Möttönen, T; Puolakka, K | 1 |
| Apraş, S; Calgüneri, M; Cobankara, V; Ertenli, I; Kiraz, S; Oztürk, MA | 1 |
| Alexopoulou, A; Apostolopoulou, A; Archimandritis, AJ; Dourakis, SP; Kandyli, A; Pandelidaki, H | 1 |
| Haapasaari, J; Hakala, M; Isomäki, H; Kautiainen, H | 1 |
| Fath, R | 1 |
| Aries, PM; Reinhold-Keller, E | 1 |
| Bansal, A; Singh, S | 1 |
| Chandrashekara, S; Patil, R; Shobha, A; Vadiraja, HS | 1 |
| Choi, KW; Ho, KM; Kun, EW; Leung, YY | 1 |
| Ahn, SJ; Choi, JH; Koh, JK; Lee, HW; Lee, MW; Moon, KC | 1 |
| Lioté, F | 1 |
| Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Aydog, E; Sever, A; Usan, H; Yesilli, O | 1 |
| Caughey, GE; Cleland, LG; James, MJ; Proudman, SM | 1 |
| Resman-Targoff, BH | 1 |
| Dijkmans, BA; Nurmohamed, MT; Twisk, JW; van Halm, VP; Voskuyl, AE | 1 |
| Bank, I; Ben-Horin, S; Langevitz, P; Levi, Y; Livneh, A; Schiby, G; Tweezer-Zaks, N | 1 |
| Allaart, CF; Breedveld, FC; de Vries-Bouwstra, JK; Dijkmans, BA; Gerards, AH; Goekoop-Ruiterman, YP; Hazes, JM; Kerstens, PJ; van der Kooij, SM; van Groenendael, JH; van Zeben, D | 1 |
| Ayres, OC; Caughey, GE; Cleland, LG; Goldblatt, F; Hill, CL; James, MJ; Keen, HI; Lee, AT; Proudman, SM; Rischmueller, M; Stamp, LK | 1 |
| Giles, JT; Golding, A; Haque, UJ | 1 |
| Matsuda, T; Ohtsubo, H | 1 |
| Amital, H; Arnson, Y; Dovrish, Z; Hadari, R | 1 |
| Andersen, LS; Ellingsen, T; Hansen, GV; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Bingham, CO; Miner, MM | 1 |
| Boswell, JS; Costner, MI | 1 |
| Mowad, CM; Sewell, LD; Wilson, ML | 1 |
| Cleland, LG; Gillis, D; Hissaria, P; James, HM; Lester, S; Proudman, SM; Somogyi, AA | 1 |
| Arnold, S; Baerwald, CG; Häntzschel, H; Malysheva, OA; Pierer, M; Wagner, U; Wahle, M | 1 |
| Capell, HA; Kincaid, W; McMahon, AD; Porter, DR; Saunders, SA; Stirling, A; Vallance, R | 1 |
| El-Kiki, HA; Emad, Y; Raafat, H; Ragab, Y; Rasker, JJ; Shaarawy, A | 1 |
| Bochkova, AG; Bunchuk, NV; Gubar', EE | 1 |
| Boers, M; Dijkmans, BA; Garnero, P; Kerstens, PJ; Lems, WF; van Tuyl, LH; Voskuyl, AE | 1 |
| D'Angelo, S; Olivieri, I; Palazzi, C | 1 |
| Anuradha, V; Chopra, A; Kunjir, V; Lagoo-Joshi, V; Saluja, M; Salvi, S | 1 |
| Lee, PC; Sha, K; Sharma, B | 1 |
| de Araujo, T; Drosou, A; Kowalczyk, JP; Nousari, CH; Ricotti, CA | 1 |
| Brasington, R | 1 |
| Francès, C | 1 |
| Allaart, CF; Dijkmans, BA; Huizinga, TW; Kerstens, PJ; Klarenbeek, NB | 1 |
| Hakala, M; Hannonen, P; Järvenpää, S; Julkunen, H; Kautiainen, H; Korpela, M; Leirisalo-Repo, M; Luosujärvi, R; Möttönen, T; Puolakka, K; Rantalaiho, V | 1 |
| Erov, NK; Sergiets, NA | 1 |
| Akre, F; Bratt, J; Chatzidionysiou, A; Cöster, L; Dackhammar, C; Ernestam, S; Forslind, K; Geborek, P; Hellström, H; Ljung, L; Oding, R; Petersson, IF; Teleman, A; Theander, J; Thörner, A; van Vollenhoven, RF; Waltbrand, E; Wörnert, M; Zickert, A | 1 |
| Díaz, J; González, A; Mora, C; Quintana, G | 1 |
| Cho, KH; Choi, JW; Kim, BK; Park, HS | 1 |
| Yoo, WH | 1 |
| Blåfield, H; Hannonen, P; Järvenpää, S; Karjalainen, A; Kautiainen, H; Korpela, M; Laasonen, L; Leirisalo-Repo, M; Möttönen, T; Puolakka, K; Rantalaiho, V | 1 |
| Mäkinen, H; Möttönen, T; Puolakka, K | 1 |
| Edmonson, MB; Gottam, CC; Hinshaw, MA; Shen, LY; Teng, JM; Williams, GP | 1 |
| Bhatia, R; Garg, R; Gleeson, T; Lu, B; Massarotti, E; Rekedal, LR; Solomon, DH | 1 |
| Brismar, K; Engvall, IL; Hafström, I; Tengstrand, B | 1 |
| Abhishek, A; Doherty, M | 1 |
| Partlett, R; Roussou, E | 1 |
| Bambery, P; Jose, V; Mittal, N; Mittal, R; Sharma, A; Wanchu, A | 1 |
| Aalto, K; Honkanen, V; Kröger, L; Lahdenne, P; Malin, M; Putto-Laurila, A; Tarkiainen, M; Tynjälä, P; Vähäsalo, P | 1 |
| Akhlaghi, S; Ferns, GA; Ghayour-Mobarhan, M; Goshayeshi, L; Hatef, MR; Mirfeizi, Z; Rezaieyazdi, Z; Sahebari, M; Sahebkar, A | 1 |
| Al-Husain, A; Bruce, IN; Mirjafari, H | 1 |
| Ganu, AS; Ganu, MA | 1 |
| Mulholland, CP; Pollock, TJ | 1 |
| Kadanoff, R; Ostrowski, RA; Tehrani, R | 1 |
| Amoura, Z; Barete, S; Benveniste, O; Bourgeois, P; Cacoub, P; Dubourg, O; Francès, C; Gatfossé, M; Lebeaux, D; Maisonobe, T; Piette, JC; Renoux, J; Sène, D; Wechsler, B | 1 |
| Arbogast, PG; Chen, L; Curtis, JR; Delzell, E; Griffin, MR; Grijalva, CG; Herrinton, L; Kawai, VK; Liu, L; Mitchel, EF; Ouellet-Hellstrom, R; Solomon, DH; Stein, CM | 1 |
| Chen, Y; Ye, S; Zhou, L | 1 |
| Cooper, SC; Douglas, KM; Tugnet, N | 1 |
| Albertsson, K; Bratt, J; Chatzidionysiou, K; Ernestam, S; Forslind, K; Geborek, P; Petersson, IF; van Vollenhoven, RF | 1 |
| Bathon, JM; Bridges, SL; Cofield, SS; Curtis, JR; Howard, G; McVie, T; Moreland, LW; O'Dell, JR; Paulus, HE; St Clair, EW; van der Heijde, D; Zhang, J | 1 |
| Chakravarty, SD; Crow, MK; Harris, ME; Schreiner, AM | 1 |
| Barendregt, PJ; de Jager, MH; de Jong, PH; de Sonnaville, PB; Gerards, AH; Grillet, BA; Hazes, JM; Huisman, M; Luime, JJ; van der Lubbe, PA; van Zeben, D; Weel, AE | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Bridges, SL; Cofield, SS; Curtis, JR; Maska, LB; Mikuls, TR; Moreland, LW; O'Dell, JR; Sayles, HR | 1 |
| Blåfield, H; Hannonen, PJ; Ilva, K; Julkunen, HA; Kaipiainen-Seppänen, O; Karjalainen, A; Kauppi, MJ; Kautiainen, H; Korpela, M; Laasonen, L; Leirisalo-Repo, M; Luosujärvi, R; Luukkainen, R; Moilanen, E; Möttönen, T; Paimela, L; Puolakka, K; Uutela, T | 1 |
| Ahmed, S; Akhter, S; Alam, MK; Bari, MA; Bhattacharjee, M; Islam, MZ; Khan, NA; Miah, AH; Pandit, H; Sutradhar, SR; Zannat, KF | 1 |
| Carroll, C; Chan, YH; Jorizzo, J; Kannagra, A; LoSicco, K; Manabat, CG; Ng, P; Tan, A; Yosipovitch, G | 1 |
| McNeill, E; Mims, JW; Wood, MW; Wright, SC | 1 |
| Cavet, G; Emerling, D; Ford, K; Li, W; Sasso, EH | 1 |
| Bratt, J; Ernestam, S; Geborek, P; Karlsson, JA; Neovius, M; Nilsson, JÅ; Petersson, IF; van Vollenhoven, RF | 1 |
| Hannonen, PJ; Kautiainen, H; Korpela, M; Leirisalo-Repo, M; Möttönen, T; Rantalaiho, VM | 1 |
| Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA | 1 |
| Bergstrom, A; Bird, HA | 1 |
| Bathon, JM; Bridges, SL; Charles-Schoeman, C; Chen, L; Cofield, SS; Curtis, JR; Dell'Italia, LJ; Moreland, LW; Navarro-Millán, I; O'Dell, JR; Paulus, HE; Yang, S | 1 |
| Forslind, K; Geborek, P; Petersson, IF; Rezaei, H; Saevarsdottir, S; van Vollenhoven, RF | 1 |
| Gabay, C; So, AK; Van Linthoudt, D | 1 |
| Bridges, SL; Cofield, SS; Curtis, JR; McVie, T; Mikuls, TR; Moreland, LW; Navarro-Millán, I; O'Dell, J; Ranganath, VK; Reynolds, RJ | 1 |
| Kiely, PD; McWilliams, DF; Walsh, DA; Young, A | 1 |
| Bridges, SL; Cofield, SS; Curtis, JR; Mikuls, TR; Moreland, LW; O'Dell, JR; Ranganath, VK | 1 |
| Allaart, CF; Bijkerk, C; de Buck, MP; de Sonnaville, PB; Goekoop, RJ; Grillet, BA; Harbers, JB; Heimans, L; Huizinga, TW; Speyer, I; van Oosterhout, M; Visser, K; Wevers-de Boer, KV | 1 |
| Abásolo, L; Fernández-Gutierrez, B; Fontsere, O; Jover-Jover, JA; León, L; Peña-Blanco, RC; Rodriguez-Rodriguez, L | 1 |
| Ahluwalia, V; Anis, AH; Brophy, M; Cannella, AC; Keystone, E; Kunkel, G; Leatherman, S; Lew, RA; Mikuls, TR; O'Dell, JR; Phibbs, CS; Taylor, TH; Warren, SR | 1 |
| Bathon, JM; McMahon, DJ | 1 |
| Yelin, E | 1 |
| Bratt, J; Eriksson, JK; Ernestam, S; Geborek, P; Neovius, M; Petersson, IF; van Vollenhoven, RF | 1 |
| Nardi, AE; Ornelas, AC; Pinho de Oliveira Ribeiro, N; Pinho de Oliveira, CM; Rafael de Mello Schier, A; Silva, AC | 1 |
| Chatzidionysiou, K; van Vollenhoven, RF | 1 |
| Hakala, M; Jämsen, E; Kauppi, MJ; Lehto, MU; Malmivaara, A; Virta, LJ | 1 |
| Loke, YK; MacGregor, AJ; Watts, RA; Yates, M | 1 |
| Eastham, AB; Femia, AN; Lam, C; Merola, JF; Qureshi, AA; Vleugels, RA | 1 |
| Cleland, LG; Flabouris, K; James, MJ; Lee, AT; Metcalf, RG; Proudman, SM; Rischmueller, M; Spargo, LD; Sullivan, TR; Wechalekar, MD | 1 |
| Krüger, K | 1 |
| Chen, DY; Chen, HH; Chen, YM; Chou, P; Chou, YJ; Huang, N; Lai, KL; Lin, CH | 1 |
| Allaart, CF; Bijkerk, C; de Buck, MP; de Sonnaville, PB; Goekoop, RJ; Harbers, JB; Heimans, L; Huizinga, TW; Kälvesten, J; Steup-Beekman, M; van Oosterhout, M; Visser, K; Wevers-de Boer, KV | 1 |
| Amoiridis, G; Bertsias, G; Boumpas, DT; Fanouriakis, A; Mastorodemos, V; Pamfil, C; Papadaki, E; Plaitakis, A; Sidiropoulos, P | 1 |
| Bijlsma, JW; Fransen, J; Janse, RW; Kievit, W; Lafeber, FP; Nair, SC; Welsing, PM | 1 |
| Agarwal, S; Das, SK | 1 |
| Ju, JH; Kwok, SK; Park, KS; Park, SH; Suh, YS; Yoon, CH | 1 |
| Callahan, ST; Cheetham, TC; Chen, N; Cooper, WO; Griffin, MR; Li, DK; Morgan, TM; Ray, WA; Shintani, AK; Stein, CM | 1 |
| Allaart, CF; Goekoop-Ruiterman, YP; Grillet, BA; Harbers, JB; Heimans, L; Huizinga, TW; Koudijs, KK; Lard, LR; Steup-Beekman, GM; Visser, K; Wevers-de Boer, KV | 1 |
| Choi, NK; Jin, XM; Kim, MS; Kim, YJ; Lee, J; Park, BJ; Seong, JM; Shin, JY; Yang, BR | 1 |
| Krause, ML; Lehman, JS; Warrington, KJ | 1 |
| Albertsson, K; Ernestam, S; Forslind, K; Geborek, P; Petersson, I; Rezaei, H; Saevarsdottir, S; van Vollenhoven, RF | 1 |
| Bratt, J; Eriksson, JK; Ernestam, S; Geborek, P; Karlsson, JA; Neovius, M; Petersson, IF; van Vollenhoven, RF | 1 |
| de Jong, PH; de Sonnaville, PB; Gerards, AH; Han, HK; Hazes, JM; Huisman, M; Luime, JJ; van der Lubbe, PA; van Krugten, MV; van Schaeybroeck, B; van Zeben, D; Weel, AE | 1 |
| Bolce, R; Chernoff, D; Cruickshank, SE; Forslind, K; Geborek, P; Hambardzumyan, K; Petersson, IF; Saevarsdottir, S; Sasso, EH; van Vollenhoven, RF | 1 |
| Biswas, M; Chatterjee, S; Ghosh, A; Ghosh, S; Sarkate, P | 1 |
| Lüscher, TF; Ridker, PM | 1 |
| Kautiainen, H; Leirisalo-Repo, M; Puolakka, K; Relas, H; Virta, LJ | 1 |
| Friedman, J; Kozak, N; Schattner, A | 1 |
| Asgaonkar, DS; Chawla, B; Khedkar, U; Londhey, V; Pandit, A; Sundaram, S | 1 |
| Aliabadi, P; Coblyn, JS; Fanta, CH; McSparron, JI; Paulson, V; Shah, N; Sparks, JA | 1 |
| Abdel, MP; Figgie, MP | 1 |
| Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
| Chang, YT; Chen, CC; Chen, DY; Chen, YJ; Ho, HJ; Kuo, KN; Liu, HN; Shen, JL; Wu, CY | 1 |
| Hämäläinen, M; Moilanen, E; Moilanen, T; Tuure, L | 1 |
| Jankowski, TA; Jones, DW; Wright, D | 1 |
| Anelli, MG; Cacciapaglia, F; Covelli, M; Iannone, F; Lapadula, G; Rinaldi, A; Scioscia, C; Serafino, L | 1 |
| Foster, DJ; Proudman, SM; Upton, RN; Wiese, MD; Wojciechowski, J | 1 |
| Hakala, M; Häkkinen, A; Järvenpää, S; Kautiainen, H; Salomaa, S; Uutela, T | 1 |
| Amlani, B; Goldberg, JW; Sehgal, R; Yachoui, R | 1 |
| Ernestam, S; Forslind, K; Geborek, P; Karlsson, JA; Kastbom, A; Klareskog, L; Lundberg, K; Petersson, IF; Saevarsdottir, S; van Vollenhoven, RF | 1 |
| Fautrel, B; Gaujoux-Viala, C; Tsonaka, R; van der Helm-van Mil, AH; van Nies, JA | 1 |
| Ahmad, NM; Asad, K; Farman, S; Saeed, MA; Shabbir, G | 1 |
| Cortés-Hernández, J; Egri, N; Ordi-Ros, J; Vilardell-Tarrés, M | 1 |
| Goodman, SM | 1 |
| Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
| Forslind, K; Levitsky, A; van Vollenhoven, RF | 1 |
| Bauerová, K; Drábiková, K; Jančinová, V; Lucová, M; Mihalová, D; Nosáľ, R; Pažoureková, S; Perečko, T | 1 |
| Bonafede, M; Collier, DH; Harrison, DJ; Johnson, BH; Shah, N; Tang, DH | 1 |
| Barton, A; Chinoy, H; Fu, B; Griffiths, CE; Hyrich, K; Isaacs, JD; Jani, M; Morgan, AW; Plant, D; Warren, RB; Wilson, AG | 1 |
| Karaarslan, AA; Kobak, Ş; Sever, F; Yilmaz, H | 1 |
| Nguyen, TT; Parker, BJ; Yachoui, R | 1 |
| Blåfield, H; Eklund, KK; Ilva, K; Kaipiainen-Seppänen, O; Karjalainen, A; Kautiainen, H; Korpela, M; Kuusalo, L; Leirisalo-Repo, M; Puolakka, K; Rantalaiho, V; Valleala, H | 1 |
| Cummins, L; Duggan, E; Katikireddi, VS; Pahau, H; Shankaranarayana, S; Su, KY; Thomas, R; Videm, V | 1 |
| Bokarewa, MI; Erlandsson, MC; Levitsky, A; van Vollenhoven, RF | 1 |
| Aboutorabi, RB; Rezaieyazdi, Z; Salari, M | 1 |
| Alfaro-Lozano, JL; Elera-Fitzcarrald, C; Pastor-Asurza, CA | 1 |
| Horneff, G; Hügle, B | 1 |
| Akdemir, G; Allaart, CF; Boer, KV; de Sonnaville, PB; Goekoop-Ruiterman, YP; Grillet, BA; Heimans, L; Huizinga, TW; Lard, LR; Molenaar, ET; Peeters, AJ; Steup-Beekman, GM; van Groenendael, JH | 1 |
| Danaei, G; Desai, RJ; Kim, SC; Liao, KP; Schneeweiss, S; Solomon, DH | 1 |
| Elfving, P; Kaipiainen-Seppänen, O; Kautiainen, H; Pohjolainen, T; Puolakka, K; Virta, LJ | 1 |
| Brill, G; Choudhry, NK; Krumme, AA; Matlin, OS; Pezalla, EJ; Shrank, WH; Solomon, DH; Sparks, JA | 1 |
| Clowse, ME; Noviani, M; Wasserman, S | 1 |
| Chang, DJ; Kan, H; Molta, C; Nagar, S; Patel, J; Wallace, DJ | 1 |
| Chen, GS; Hu, SC; Lin, CL; Lin, YC; Wang, TN; Yen, FL | 1 |
| Eriksson, JK; Ernestam, S; Miller, H; Neovius, M; Petersson, IF; van Vollenhoven, RF; Vivar, N; Wallman, JK | 1 |
| Bridges, SL; Cofield, S; Curtis, JR; Jalal, H; Michaud, K; Mikuls, TR; Moreland, LW; O'Dell, JR | 1 |
| Garza-Mayers, AC; McClurkin, M; Smith, GP | 1 |
| Gogia, SB; Malaviya, AN | 1 |
| Cannon, GW; Curtis, JR; Harrison, DJ; Leng, J; Mikuls, TR; Sauer, BC; Tang, D; Teng, CC | 1 |
| Ho, A; Kurtzman, DJ; Rubenstein, MH; Vleugels, RA; Wright, NA | 1 |
| Gerosa, M; Meroni, PL; Schioppo, T | 1 |
| Bansback, N; Lacaille, D; Shojania, K | 1 |
| Cleland, LG; Hall, C; Lee, AT; McWilliams, L; Metcalf, RG; Proudman, SM; Sorich, MJ; Spargo, LD; Wabe, NT; Wechalekar, MD; Wiese, MD | 1 |
| Blevins, G; Emery, D; Gross, D; Lu, JQ; Power, C; Ringrose, J | 1 |
| Bathon, J; Charles-Schoeman, C; Chen, L; Cofield, SS; Curtis, JR; Elashoff, D; Louis Bridges, S; Moreland, LW; Navarro-Millán, I; O'Dell, J; Paulus, H; Reddy, ST; Shahbazian, A; Wang, X; Yang, S; Yin Lee, Y | 1 |
| Aringer, M; Schneider, M | 1 |
| Avery, M; Holmqvist, ME; Michaud, K; Ozen, G; Pedro, S; Wolfe, F | 1 |
| Carbonell-Abelló, J; Corzo, P; Mojal, S; Polino, L; Salman-Monte, TC; Torrente-Segarra, V | 1 |
| Baillet, A; Bernard, AC; Clay, M; Gaudin, P; Mazouyès, A | 1 |
| Bolce, RJ; Ernestam, S; Forslind, K; Hambardzumyan, K; Petersson, IF; Saevarsdottir, S; van Vollenhoven, RF; Wallman, JK | 1 |
| Brophy, MT; Chang, BH; Hannagan, K; O'Dell, JR; Quach, LT; Soe Thwin, S | 1 |
| Huang, L; Kuang, Y; Li, W; Pang, J; Wei, D; Yang, Y; Yin, Q; Zhang, Z | 1 |
| Chen, DY; Chen, YM; Liao, TL; Liu, HJ | 1 |
| Gladman, DD; Pakchotanon, R; Polachek, A; Su, J; Tselios, K; Urowitz, MB; Yap, KS | 1 |
| Aaltonen, K; Asikainen, J; Ekman, P; Hannonen, P; Isomäki, P; Kauppi, M; Kautiainen, H; Kortelainen, S; Kuusalo, L; Laiho, K; Mäkinen, H; Mali, M; Nyrhinen, S; Paltta, J; Pirilä, L; Puurtinen-Vilkki, M; Rannio, T; Sokka, T; Taimen, K; Uotila, T; Yli-Kerttula, T | 1 |
| Davis, LS; Reimold, AM | 1 |
| Brophy, M; Lew, R; Mikuls, T; O'Dell, J; Peper, SM; Rybin, D; Wu, H | 1 |
| Combe, B; De Bandt, M; Lukas, C; Mary, J; Morel, J | 1 |
| Ciechomska, M; Horsburgh, S; O'Reilly, S | 1 |
| Asemi, Z; Bahmani, F; Farshbaf, S; Golkar, HR; Zamani, B | 1 |
| Dangi, A; Rajput, R; Singh, H | 1 |
| Guo, Y; Nagpal, S; Proudman, SM; Smith, MD; Walsh, AM; Wechalekar, MD; Weedon, H; Yin, X | 1 |
| Cleland, LG; Lee, A; McWilliams, L; Proudman, S; Wabe, N; Wechalekar, MD; Wiese, MD; Wojciechowski, J | 1 |
| Akdemir, G; Allaart, CF; Bergstra, SA; de Sonnaville, PBJ; Goekoop, RJ; Grillet, BAM; Heimans, L; Huizinga, TWJ; Lard, LR; Peeters, AJ; Steup-Beekman, GM; van Groenendael, JHLM; van Oosterhout, M | 1 |
| Bombardier, C; Hazlewood, GS; Marshall, D; Tomlinson, G | 1 |
| Guo, C; Wu, R; Zheng, N | 1 |
| Campanilho-Marques, R; Deakin, CT; Moraitis, E; Pilkington, CA; Pullenayegum, E; Simou, S; Wedderburn, LR | 1 |
| Chen, CH; Chen, CM; Chiou, JY; Leong, PY; Li, YC; Lin, LC; Tam, HW; Wang, YH; Wei, JC | 1 |
| Cervera Taulet, E; Hernández Bel, L; Hernández Garfella, M; Monferrer Adsuara, C | 1 |
| Callen, JP; Tidwell, WJ | 1 |
| Berman, JS; Govender, P; Raghu, G | 1 |
| Breuer, O; Schultz, A | 1 |
| Baker, JF; Cannella, A; Cannon, GW; Caplan, L; Davis, LA; England, BR; George, M; Ibrahim, S; Michaud, K; Mikuls, TR; OʼDell, J; Sauer, B; Teng, CC | 1 |
| Bijlsma, JWJ; Borm, MEA; de Jong, PHP; Hazes, JMW; Jacobs, JWG; Lafeber, FPJG; Pethö-Schramm, A; Teitsma, XM; van Laar, JM; Weel, AEAM; Welsing, PMJ | 1 |
| Fernández-Codina, A; Pope, JE; Walker, KM | 1 |
| Allaart, CF; Bergstra, SA; Chopra, A; Govind, N; Landewé, RBM; Murphy, EA; Ramiro, S; Silva, C | 1 |
| Lueangarun, S; Subpayasarn, U; Tempark, T | 1 |
| den Broeder, AA; Gevers, LAHA; Schapink, L; van den Ende, CHM; van Ede, AE | 1 |
| Cannon, GW; Curtis, JR; Erhardt, DP; Mikuls, TR; Sauer, BC; Teng, CC | 1 |
| Adegun, O; Carey, B; Hodgson, T | 1 |
| Bazzichi, L; Bianchino, L; Caporali, R; Nacci, F; Sinigaglia, L | 1 |
| Yates, M | 1 |
| Cappelli, LC; Darrah, E; Mikuls, TR; O'Dell, JR; Rosen, A; Yu, F | 1 |
| Bertolo, MB; Brenol, CV; Castelar Pinheiro, GDR; Cruz, BA; de Albuquerque, CP; de Freitas, MVC; Duarte, ALBP; Giorgi, RDN; Gomides, APM; Kakehasi, AM; Laurindo, IMM; Louzada-Júnior, P; Mota, LMHD; Pereira, IA; Ubirajara Silva de Souza, MPG; Xavier, RM | 1 |
| Li, RN; Lin, CH; Lin, YZ; Ou, TT; Sung, WY; Tsai, WC; Tseng, CC; Wu, CC; Yen, JH | 1 |
| Sheikh, ASF; Wong, E | 1 |
| Cai, YM; Gan, YZ; He, J; Li, J; Li, R; Li, SG; Li, ZG; Liao, H; Liu, JJ; Liu, X; Shi, LJ; Sun, XL; Xu, J; Ye, H; Zhang, RJ; Zhao, JX | 1 |
| Atia, NN; El-Koussi, WM; Hammam, N; Saleh, GA | 1 |
| Boulos, D; Hall, C; McWilliams, L; Metcalf, RG; Proudman, SM; Wicks, IP | 1 |
| Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
| Blanco, P; Duffau, P; Lazaro, E; Martin-Cascon, M; Richez, C; Ruiz-Arruza, I; Ruiz-Estevez, B; Ruiz-Irastorza, G; Ugarte, A | 1 |
| Arnaud, L; Ben Hassine, I; Bielefeld, P; Cacoub, P; Chanson, N; Chapelon-Abric, C; Comarmond, C; Devilliers, H; Glanowski, C; Groh, M; Hirschi, S; Meunier, B; Rein, C; Richez, C; Saadoun, D; Sacré, K; Saidenberg-Kermanac'h, N; Scherlinger, M; Schleinitz, N | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Bessette, L; Haraoui, B; Lazovskis, J; Pope, J; Rampakakis, E; Sampalis, JS; Vaillancourt, J | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Li, J; Xie, W; Zhang, Z | 1 |
| Cantagrel, A; Combe, B; Daïen, C; Debandt, M; Fautrel, B; Lukas, C; Mary, J; Morel, J | 1 |
| Chu, AD; Deodhar, A; Everding, A; Kim, TH; Kishimoto, M; Maksymowych, WP; Pangan, AL; Sieper, J; Song, IH; Sui, Y; van den Bosch, F; van der Heijde, D; Wang, X | 1 |
| Aalto, K; Kröger, L; Lahdenne, P; Tarkiainen, M; Tynjälä, P; Vähäsalo, P | 1 |
| Davis, LS; Hess, JN; Ward, JM | 1 |
| Cash, K; Greenberg, SA; Hissaria, P; Koszyca, B; Limaye, VS; Patel, S; Smith, C | 1 |
| Bértolo, MB; Bonfiglioli, KR; Brenol, CV; da Mota, LMH; da Rocha Castelar Pinheiro, G; de Albuquerque, CP; de Fátima Lobato da Cunha Sauma, M; Giorgi, RDN; Gomides, APM; Júnior, PL; Pereira, IA; Radominski, SC; Resende Guimarães, MFB; Santos, ABV | 1 |
| Arthur, M; Cardones, AR; Femia, A; Fernandez, AP; Fett, NM; Florez-Pollack, S; Gaffney, R; Houser, J; Jacobe, H; Knabel, D; Kunzler, E; Latour, E; Laumann, A; Leung, N; Lo, K; Pappas-Taffer, LK; Prasad, S; Sharma, S; Stern, MJ; Tkachenko, E; Vleugels, RA; Yu, JM; Zhao, J | 1 |
| Curtis, JR; Greenberg, J; Harrold, LR; Kremer, JM; Palmer, JL; Pappas, DA; Reed, GW | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Ji, L; Xie, W; Yang, X; Zhang, Z | 1 |
| Bhandari, S; Jain, G; Kalra, S; Vasnik, G | 1 |
| Alvaro-Gracia, JM; Diaz-Torne, C; Gomez-Reino, J; Gonzalez-Gay, MA; Manero, J; Pego-Reigosa, JM; Rúa-Figueroa, Í; Sanchez-Piedra, C | 1 |
| Du, H; Fan, J; Hua, L; Shi, X; Wu, H; Ying, M | 1 |
| Deng, D; Li, M; Li, S; Tian, L; Wang, T; Wu, J; Yang, J; Zeng, F; Zhou, J; Zou, J | 1 |
| El-Banna, HS; Gado, SE | 1 |
| Gasparyan, AY; Misra, DP; Zimba, O | 1 |
| Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N | 1 |
| Hammad, I; Porter, TF | 1 |
| Askling, J; Ernestam, S; Miller, H; Neovius, M; Petersson, IF; Saevarsdottir, S; Söderling, J; van Vollenhoven, R; Wallman, JK | 1 |
| Charan, N; Kam, JK; Leong, RW; Loh, ZW; Thong, BY | 1 |
| Baecklund, E; Bakland, G; Brodin, E; Cagnotto, G; Ellingsen, T; Faustini, F; Grondal, G; Grøn, KL; Gudbjornsson, B; Haavardsholm, EA; Heiberg, MS; Hendricks, O; Hetland, ML; Hultgård Ekwall, AK; Husmark, T; Hyldstrup, LH; Hørslev-Petersen, K; Just, SA; Kapetanovic, M; Krabbe, S; Lampa, J; Larsson, P; Laurberg, TB; Lend, K; Lindqvist, J; Ljoså, MA; Lorenzen, T; Nordström, D; Nurmohamed, M; Olsen, IC; Olsson, ÅR; Rizk, M; Rudin, A; Söderbergh, A; Sokka-Isler, T; Stevens, DJ; Tuompo, R; Twisk, J; Uhlig, T; Uhrenholt, L; van Vollenhoven, R; Vedder, D; Østergaard, M | 1 |
| Hasan, SS; Kow, CS | 1 |
| Alexander, RV; Brady, K; Kammesheidt, A; Rudolph, M; Stimson, D | 1 |
| de Mattos, ABN; Furian, MEA; Garbo Baroni, L; Zanotto, LL | 1 |
| Birring, S; Brex, P; Galloway, J; Larkin, G; Murgatroyd, F; Paolino, A; Patel, A; Sado, D; Walsh, S | 1 |
| Dörks, M; Douros, A; Hoffmann, F; Jobski, K | 1 |
| Ji, P; Wu, Y; Yan, X; Yang, L; Zhang, Z; Zhao, J; Zhou, W | 1 |
| C Kapetanovic, M; Einarsson, JT; Geborek, P; Källmark, H; Nilsson, JÅ; Olofsson, T; Saxne, T | 1 |
| Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C | 1 |
| Chen, J; Cooper, D; Norling, LV | 1 |
| Aga, AB; Bakland, G; Fremstad, H; Haavardsholm, EA; Hansen, IJW; Hansen, IM; Haukeland, H; Høili, CA; Kvien, TK; Lexberg, Å; Lillegraven, S; Ljoså, MA; Madland, TM; Moholt, E; Olsen, IC; Paulshus Sundlisæter, N; Sexton, J; Solomon, DH; Spada, C; Uhlig, T; van der Heijde, D | 1 |
| Ehrenstein, MR; Embleton-Thirsk, A; Mukerjee, D; Shipa, MRA; Yeoh, SA | 1 |
| Ahmanna Chakir, F; Dudler, J; Folly, A | 1 |
| Bhattarai, P; Correa, LB; de Oliveira Henriques, MDGM; Gemini Piperni, S; Helal-Neto, E; Iram, SH; Magne, TM; Rebelo Alencar, LM; Ricci-Junior, E; Rosas, EC; Santos-Oliveira, R; Zhu, L | 1 |
| Al-Obaidi, M; Ciurtin, C; Doolan, G; Faizal, NM; Foley, C; Jury, EC; Lieberman, SM; Price, E; Ramanan, AV | 1 |
| Belani, PJ; Kavadichanda, CG; Negi, VS | 1 |
| Ma, RR; Wu, F; Wu, TJ; Ying, ZH; Yu, JJ; Zhang, Y | 1 |
| Desai, RJ; Glynn, RJ; He, M; Kim, SC; Lee, H; Pawar, A; Solomon, DH; Weinblatt, ME | 1 |
| Consani Fernández, SA; Díaz Cuña, CL; Facal Castro, JA; Fernández Rey, L; Maciel Oleggini, G; Rostán Sellanes, S | 1 |
| Bruun, JM; Hundahl, MP; Kjolby, M; Kragstrup, TW; Mikkelsen, RR; Rodríguez-Carrio, J; Torp, CK | 1 |
| Chen, SK; Desai, RJ; Gautam, N; Glynn, RJ; He, M; Kim, SC; Lee, H; Vine, SM; Weinblatt, ME | 1 |
| Askling, J; Barbulescu, A; Frisell, T; Kim, SC; Saevarsdottir, S | 1 |
| Fernando, D; Herath, T; Rajapakse, S; Rodrigo, C; Wickramarachchi, U | 1 |
| Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP | 1 |
| Chang, JC; Costenbader, KH | 1 |
| D'Andrea, E; Desai, RJ; Glynn, RJ; He, M; Kim, SC; Lee, H; Weinblatt, ME | 1 |
| Mathieu, S; Sellam, J; Soubrier, M; Tournadre, A | 1 |
| Kotar, AM; Smedslund, G; Uhlig, T | 1 |
| Duruöz, MT; Esen, İ; Gezer, HH; Karabulut, Y; Öz, N | 1 |
| Ahmed, A; Arundel, C; Cheng, Y; Dowell, S; Faselis, C; Fletcher, RD; Fonarow, GC; Heimall, MS; Joseph, JK; Karasik, PE; Kerr, GS; Liappis, AP; Moore, HJ; Quiñones, ME; Sheriff, HM; Taub, DD; Zeng-Treitler, Q; Zhang, S | 1 |
| Han, B; Liu, H; Wang, H | 1 |
| Chen, L; Li, HJ; Lin, SP; Zheng, YQ | 1 |
| Barrett, R; Culliford, D; Edwards, CJ; Fraser, S; Lin, SX | 1 |
| Barnabe, C; Bullen, J; Bunzli, S; Conley, B; Grainger, R; Gunatillake, T; Lin, I; Nikpour, M; O'Brien, P; Persaud, J | 1 |
| Deme, A; Lissimo, H; Sabounji, MM | 1 |
| Lomanto Silva, R; Magnani, JW; Sattui, SE; Swabe, GM | 1 |
| Harrell, K; Jensen, ME; McBride, JD | 1 |
| Ahmadi, F; Blake, PG; Garg, AX; Kim, RB; McArthur, E; Muanda, FT; Sontrop, JM; Urquhart, BL; Weir, MA | 1 |
84 review(s) available for hydroxychloroquine and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anti-inflammatory drugs in the treatment of allergic disease.
Topics: Adrenergic beta-Agonists; Anti-Inflammatory Agents; Asthma; Auranofin; Bronchodilator Agents; Cromolyn Sodium; Drug Therapy, Combination; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Methotrexate; Quality of Life; Severity of Illness Index; Steroids; Theophylline; Troleandomycin | 1992 |
Pharmacological management of juvenile rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Child; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Organogold Compounds; Penicillamine | 1992 |
Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Penicillamine | 1991 |
Severe rheumatoid arthritis: current options in drug therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arthritis, Rheumatoid; Aspirin; Clinical Protocols; Cyclosporins; Drug Therapy, Combination; Fatty Acids, Omega-3; Glucosamine; Humans; Hydroxychloroquine; Interferon-gamma; Methotrexate; Ribose | 1990 |
Rheumatoid arthritis. Practical use of medications.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate | 1990 |
Immunoregulatory drugs in the treatment of juvenile rheumatoid arthritis (JRA).
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Clinical Trials as Topic; Cyclosporins; Gold; Humans; Hydroxychloroquine; Methotrexate | 1988 |
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Felty Syndrome; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leukapheresis; Lung Diseases; Lymphoid Tissue; Methotrexate; Penicillamine; Plasmapheresis; Radiotherapy; Rheumatic Diseases; Salicylates; Sjogren's Syndrome; Spinal Diseases; Vasculitis | 1986 |
Longterm methotrexate therapy in rheumatoid arthritis: a review.
Topics: Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Drug Resistance; Gold; Humans; Hydroxychloroquine; Liver Diseases; Liver Function Tests; Methotrexate; Penicillamine; Prednisone; Psoriasis; Risk | 1985 |
Corticosteroid sparing agents in asthma.
Topics: Adrenal Cortex Hormones; Asthma; Cyclosporine; Gold; Humans; Hydroxychloroquine; Methotrexate | 1995 |
Treatment of juvenile rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Erythropoietin; gamma-Globulins; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Nutritional Physiological Phenomena; Pain Management; Pregnenediones; Sulfasalazine | 1993 |
Alternative pharmacotherapies for steroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin | 1995 |
Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Child; Child, Preschool; Double-Blind Method; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Penicillamine; Prospective Studies; Treatment Outcome | 1993 |
Early, aggressive therapy for rheumatoid arthritis: concerns, descriptions, and estimate of outcome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 1993 |
New focus on treatment for rheumatoid arthritis.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Rheumatoid; Dogs; Humans; Hydroxychloroquine; Methotrexate; Rats | 1993 |
Drug treatment of arthritis. Update on conventional and less conventional methods.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Glucosamine; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Osteoarthritis; Ribose | 1993 |
The role of anti-malarials in rheumatoid arthritis--the American experience.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Liver; Methotrexate; United States | 1996 |
Alternative treatments in the patient with intractable asthma.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Asthma; Cyclosporine; Dapsone; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Organogold Compounds; SRS-A; Troleandomycin | 1997 |
Combination of second-line antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1997 |
[Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclosporins; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Organogold Compounds; Penicillamine; Prospective Studies; Randomized Controlled Trials as Topic; Sulfasalazine | 1997 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1998 |
[Rheumatoid polyarthritis: etiology, diagnosis, course, treatment principles].
Topics: Adrenal Cortex Hormones; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Cytokines; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Organogold Compounds; Prognosis; Radiography; Sulfasalazine | 1999 |
Rheumatoid arthritis: new developments in the use of existing therapies.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Prednisolone; Sulfasalazine | 1999 |
Medical treatment of adolescents with rheumatic disease.
Topics: Adolescent; Adolescent Medicine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Pregnancy; Rheumatic Diseases; Sulfasalazine | 1998 |
Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate; Organogold Compounds; Sulfasalazine; Treatment Refusal | 2000 |
Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Costs; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Factors; Sulfasalazine | 2001 |
Disease modifying antirheumatic drugs: longterm safety issues.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate; Safety; Sulfasalazine; Treatment Outcome | 2001 |
Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inhibitors; Digestive System; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Lactones; Leflunomide; Methotrexate; Osteoarthritis; Pyrazoles; Receptors, Tumor Necrosis Factor; Sulfasalazine; Sulfonamides; Sulfones | 2001 |
Dermatomyositis.
Topics: Adult; Azathioprine; Child; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Methotrexate; Polymyositis; Prednisone; Prognosis | 2001 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Advances in the medical management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Steroids; Sulfasalazine; Treatment Outcome | 2002 |
Methotrexate: vital new information about a middle aged drug.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Availability; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydroxychloroquine; Liver; Methotrexate; Treatment Outcome | 2002 |
[Gastrointestinal side effects in the therapy of rheumatologic diseases].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Etanercept; Gastrointestinal Diseases; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Stomach Ulcer; Sulfasalazine; Tumor Necrosis Factor-alpha | 2002 |
[Combination therapy in rheumatoid arthritis].
Topics: Adjuvants, Immunologic; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine | 2003 |
Newer approaches to the treatment of rheumatoid arthritis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Receptors, Tumor Necrosis Factor | 2003 |
Rheumatoid arthritis: more aggressive approach improves outlook.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Complementary Therapies; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Time Factors | 2004 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction.
Topics: Arthritis, Rheumatoid; Azathioprine; Disease Progression; Humans; Hydroxychloroquine; Immunologic Factors; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine | 2004 |
[Armentarium and strategies for the treatment of rheumatoid arthritis].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Therapy, Combination; Family Practice; Humans; Hydroxychloroquine; Meta-Analysis as Topic; Methotrexate; Rheumatology; Risk Assessment; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2005 |
Medical therapy: where are we now?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Treatment Outcome | 2006 |
Rheumatoid arthritis and reproduction.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lactation; Methotrexate; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, High-Risk; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Effective combination therapy of TNF antagonists with DMARDs].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
Treatment, management, and monitoring of established rheumatoid arthritis.
Topics: Abatacept; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Drug Therapy, Combination; Etanercept; Humans; Hydrotherapy; Hydroxychloroquine; Immunoconjugates; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Physical Therapy Modalities; Primary Health Care; Prognosis; Quality of Life; Receptors, Tumor Necrosis Factor; Rituximab; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2007 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rheumatoid; Chronic Disease; Cryoglobulinemia; Cyclooxygenase 2 Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Hydroxychloroquine; Interferon-alpha; Methotrexate; Penicillamine; Purpura | 2008 |
The BeSt story: on strategy trials in rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Infliximab; Methotrexate; Prednisolone; Sulfasalazine | 2009 |
Adult onset Still's disease following influenza vaccination.
Topics: Aged; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Influenza Vaccines; Influenza, Human; Methotrexate; Prednisolone; Still's Disease, Adult-Onset; Treatment Outcome | 2010 |
[The goal for the treatment of rheumatoid arthritis should be remission].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Finland; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine | 2010 |
Pathophysiology of articular chondrocalcinosis--role of ANKH.
Topics: Animals; Ankylosis; Calcium Pyrophosphate; Chondrocalcinosis; Crystallization; Humans; Hydroxychloroquine; Interleukin-1; Methotrexate; Mutation; Phosphate Transport Proteins; Risk Factors | 2011 |
The treatment of rheumatoid arthritis during pregnancy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine; Tumor Necrosis Factor-alpha | 2011 |
Cardiovascular risk factors in inflammatory arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hydroxychloroquine; Methotrexate; Risk Factors | 2011 |
Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Interferon-beta; Methotrexate; Multiple Sclerosis; Prednisone; Radiography, Thoracic; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dapsone; Female; Giant Cell Arteritis; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Vasculitis | 2014 |
Anti-inflammatory therapies for cardiovascular disease.
Topics: Adaptive Immunity; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; C-Reactive Protein; Carrier Proteins; Cell Adhesion Molecules; Colchicine; Humans; Hydroxychloroquine; Interleukin-1; Interleukin-6; Leukotriene Antagonists; Lipoproteins, HDL; Methotrexate; NLR Family, Pyrin Domain-Containing 3 Protein; Phospholipase A2 Inhibitors; Receptors, Interleukin-1; Serpins; Signal Transduction; Sirtuins; Thrombosis; Tumor Necrosis Factor-alpha; Vaccination | 2014 |
Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms.
Topics: Anemia, Aplastic; Anti-Bacterial Agents; Arthritis, Rheumatoid; Bone Marrow; Etanercept; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Hydroxychloroquine; Immunoglobulin G; Methotrexate; Middle Aged; Pancytopenia; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2014 |
Surgical management of the juvenile idiopathic arthritis patient with multiple joint involvement.
Topics: Abnormalities, Multiple; Arthritis, Juvenile; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Comprehensive Health Care; Humans; Hydroxychloroquine; Methotrexate; Perioperative Care; Reoperation; Tumor Necrosis Factor-alpha | 2014 |
Clinical inquiry. What treatments relieve arthritis and fatigue associated with systemic lupus erythematosus?
Topics: Antirheumatic Agents; Arthritis; Disease Management; Exercise Therapy; Fatigue; Fish Oils; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Randomized Controlled Trials as Topic; Self Care; Symptom Assessment; Treatment Outcome | 2014 |
Rheumatoid arthritis: Perioperative management of biologics and DMARDs.
Topics: Abatacept; Adalimumab; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement; Biological Products; Etanercept; Humans; Hydroxychloroquine; Methotrexate; Perioperative Care; Prosthesis-Related Infections; Rituximab | 2015 |
Bone and bone marrow involvement in sarcoidosis.
Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Humerus; Hydroxychloroquine; Ilium; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patella; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Whole Body Imaging | 2015 |
[Update on Current Care Guidelines. Rheumatoid Arthritis (RA)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Decision Making; Exercise Therapy; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Practice Guidelines as Topic; Referral and Consultation; Sulfasalazine | 2015 |
The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Drug Therapy, Combination; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Quality of Life; Sulfasalazine | 2016 |
Review of treatment for discoid lupus erythematosus.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; Lupus Erythematosus, Discoid; Methotrexate; Phototherapy; Retinoids; Smoking Cessation; Thalidomide | 2016 |
Challenges and treatment options for rheumatoid arthritis during pregnancy.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine; Treatment Outcome | 2016 |
[Management of systemic lupus erythematosus].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Combined Modality Therapy; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Patient Care Management; Patient Care Planning; Treatment Outcome | 2016 |
Efficacy of triple association methotrexate, sulfasalazine and hydroxychloroquine in early treatment of rheumatoid arthritis with insufficient response to methotrexate: Meta-analysis of randomized controlled trials.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Pain Measurement; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome | 2017 |
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Discovery; Glucocorticoids; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Lupus Erythematosus, Systemic; Methotrexate; Molecular Targeted Therapy; Mycophenolic Acid; Recombinant Fusion Proteins; Rituximab; Ustekinumab; Vitamin D | 2017 |
Treatment of Sarcoidosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis | 2018 |
Side effects of medications used to treat childhood interstitial lung disease.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Azithromycin; Child; Cyclophosphamide; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Methylprednisolone; Off-Label Use; Prednisolone; Rituximab | 2018 |
Distinctive lupus panniculitis of scalp with linear alopecia along Blaschko's lines: a review of the literature.
Topics: Administration, Oral; Adrenal Cortex Hormones; Alopecia; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Panniculitis, Lupus Erythematosus; Prednisolone; Scalp Dermatoses | 2019 |
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus; Glucocorticoids; Humans; Hydroxychloroquine; Incidence; Methotrexate; Risk Assessment; Tumor Necrosis Factor-alpha | 2020 |
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
Topics: Antirheumatic Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hydroxychloroquine; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms | 2021 |
An Update on Biologic Agents During Pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Interventions for cutaneous disease in systemic lupus erythematosus.
Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up | 2021 |
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Etanercept; Heart Failure; Humans; Hydroxychloroquine; Inflammation; Methotrexate; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Stroke Volume; Sulfasalazine | 2021 |
[Methotrexate use: untangling the real from the fake].
Topics: Antirheumatic Agents; Folic Acid; Humans; Hydroxychloroquine; Methotrexate | 2021 |
Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Rituximab; Sjogren's Syndrome | 2022 |
Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: A bedside-to-bench approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Etanercept; Humans; Hydroxychloroquine; Immunomodulating Agents; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-1beta; Methotrexate; Sulfasalazine | 2022 |
Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials.
Topics: Anti-Inflammatory Agents; Arthralgia; Chikungunya Fever; Chloroquine; Humans; Hydroxychloroquine; Methotrexate; Observational Studies as Topic; Retrospective Studies; Ribavirin | 2022 |
Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: A meta-analysis.
Topics: Antirheumatic Agents; Humans; Hydroxychloroquine; Inflammation; Interleukin-1; Methotrexate; Osteoarthritis; Pain; Quality of Life | 2022 |
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Hydroxychloroquine; Methotrexate; Sarcoidosis; Tumor Necrosis Factor Inhibitors | 2022 |
What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate; Practice Guidelines as Topic; Sulfasalazine | 2023 |
93 trial(s) available for hydroxychloroquine and methotrexate
| Article | Year |
|---|---|
Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Penicillamine | 1991 |
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.
Topics: Alanine Transaminase; Analysis of Variance; Arthritis, Rheumatoid; Aspartate Aminotransferases; Aspirin; Canada; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Liver; Methotrexate; Product Surveillance, Postmarketing; Prospective Studies; Regression Analysis; United States | 1990 |
Immunoregulatory drugs in the treatment of juvenile rheumatoid arthritis (JRA).
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Clinical Trials as Topic; Cyclosporins; Gold; Humans; Hydroxychloroquine; Methotrexate | 1988 |
Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.
Topics: Adult; Aged; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Receptors, Interleukin-2; Severity of Illness Index; Sulfasalazine | 1995 |
Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Data Interpretation, Statistical; Disability Evaluation; Disease Progression; Female; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Penicillamine; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 1994 |
Validity of single variables and indices to measure disease activity in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; C-Reactive Protein; Disabled Persons; Hemoglobins; Humans; Hydroxychloroquine; Joints; Methotrexate; Pain; Reproducibility of Results; Severity of Illness Index; Sulfasalazine | 1993 |
Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Child; Child, Preschool; Double-Blind Method; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Penicillamine; Prospective Studies; Treatment Outcome | 1993 |
The relative toxicity of disease-modifying antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Longitudinal Studies; Methotrexate; Penicillamine; Prednisone; Prospective Studies | 1993 |
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Remission Induction; Sulfasalazine; Treatment Outcome | 1996 |
Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Treatment Outcome | 1996 |
Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome | 1996 |
Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Contrast Media; Evaluation Studies as Topic; Female; Gadolinium DTPA; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Organometallic Compounds; Pentetic Acid; Remission Induction; Remission, Spontaneous; Wrist | 1997 |
Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine.
Topics: Aged; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Time Factors; Treatment Outcome | 1997 |
[Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment].
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Time Factors | 1998 |
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Sulfasalazine | 1999 |
Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.
Topics: Adult; Aged; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Penicillamine; Prospective Studies; Sulfasalazine | 2000 |
Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Injections, Intramuscular; Male; Methotrexate; Middle Aged; Organogold Compounds; Prospective Studies; Treatment Outcome | 2000 |
Combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis. An open 3-year study.
Topics: Adult; Arthritis, Rheumatoid; Disease Progression; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 2000 |
Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Hydroxychloroquine; Hypertension; Hypertrichosis; Linear Models; Male; Methotrexate; Middle Aged; Pilot Projects; Treatment Outcome | 2001 |
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisolone; Remission Induction; Sulfasalazine; Treatment Outcome | 2002 |
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome | 2002 |
Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Biological Availability; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Injections, Intravenous; Male; Methotrexate; Middle Aged; Tablets | 2002 |
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Disability Evaluation; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Organogold Compounds; Prospective Studies; Radiography; Treatment Outcome | 2003 |
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2005 |
Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Disability Evaluation; Drug Therapy, Combination; Early Diagnosis; Employment; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Insurance Benefits; Male; Methotrexate; Middle Aged; Pensions; Prednisolone; Sulfasalazine | 2004 |
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
Topics: Adult; Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prognosis; Severity of Illness Index; Treatment Outcome | 2004 |
A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Organogold Compounds; Pain Measurement; Prognosis; Proportional Hazards Models; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome | 2005 |
Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Drug Therapy, Combination; E-Selectin; Female; Health Status; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Sulfasalazine; Thrombomodulin; Treatment Outcome | 2004 |
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Sick Leave; Sulfasalazine; Time Factors; Work Capacity Evaluation | 2005 |
Combination therapies in spondyloarthropathies.
Topics: Adult; Arthritis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Radiography; Spondylarthropathies; Sulfasalazine; Treatment Outcome | 2004 |
The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibody Specificity; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Folic Acid; Follow-Up Studies; Humans; Hydroxychloroquine; Immunoglobulins; Male; Methotrexate; Middle Aged; Proteus Infections; Proteus mirabilis; Remission Induction; Serologic Tests; Steroids | 2006 |
Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arachidonic Acid; Arthritis, Rheumatoid; Cardiovascular Diseases; Dietary Supplements; Dinoprostone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eicosanoids; Female; Fish Oils; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Risk Factors; Sulfasalazine; Thromboxane A2 | 2006 |
Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Kaplan-Meier Estimate; Leflunomide; Male; Methotrexate; Middle Aged; Prednisone; Sulfasalazine; Treatment Failure; Treatment Outcome | 2007 |
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fish Oils; Glucocorticoids; Humans; Hydroxychloroquine; Longitudinal Studies; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2007 |
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Betamethasone; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Single-Blind Method; Sulfasalazine | 2008 |
[Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Topics: Adult; Aged; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Pain Measurement; Remission Induction; Sulfasalazine; Treatment Outcome | 2008 |
Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Collagen Type II; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisolone; Remission Induction; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2008 |
The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisolone; Sulfasalazine; Treatment Outcome | 2009 |
[Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil].
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Folic Acid; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Young Adult | 2009 |
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Drug Therapy, Combination; Finland; Follow-Up Studies; Foot Joints; Hand Joints; Humans; Hydroxychloroquine; Longitudinal Studies; Methotrexate; Prednisolone; Radiography; Sulfasalazine; Treatment Outcome | 2010 |
Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.
Topics: Absorptiometry, Photon; Adiponectin; Adipose Tissue; Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Apolipoproteins; Arthritis, Rheumatoid; Body Composition; Bone Density; Bone Remodeling; Female; Humans; Hydroxychloroquine; Infliximab; Insulin-Like Growth Factor I; Leptin; Male; Methotrexate; Middle Aged; Radioimmunoassay; Sulfasalazine | 2010 |
Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
Topics: Adolescent; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Drug Combinations; Epidemiologic Methods; Female; Glucocorticoids; Humans; Hydroxychloroquine; Infliximab; Injections, Intra-Articular; Male; Methotrexate; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Therapy; Drug Resistance; Drug Therapy, Combination; Female; Foot Bones; Hand Bones; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Radiography; Sulfasalazine; Tumor Necrosis Factor-alpha | 2012 |
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Radiography; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2012 |
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Induction Chemotherapy; Injections, Intramuscular; Male; Methotrexate; Middle Aged; Recovery of Function; Sulfasalazine | 2013 |
Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Cotinine; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Longitudinal Studies; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Smoking; Sulfasalazine; Treatment Outcome | 2012 |
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Early Medical Intervention; Female; Humans; Hydroxychloroquine; Induction Chemotherapy; Infliximab; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisolone; Sulfasalazine; Treatment Outcome | 2013 |
Comparative study on methotrexate and hydroxychloroquine in the treatment of rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate; Middle Aged | 2012 |
Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged | 2013 |
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Quality of Life; Quality-Adjusted Life Years; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 2013 |
Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome | 2013 |
Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial.
Topics: Absorptiometry, Photon; Analysis of Variance; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density; Chi-Square Distribution; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Female; Hand Bones; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Odds Ratio; Predictive Value of Tests; Risk Assessment; Risk Factors; Sulfasalazine; Sweden; Time Factors; Treatment Outcome | 2013 |
Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Drug Therapy, Combination; Etanercept; Female; Health Status; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Prognosis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Symptom Assessment; Time Factors; Treatment Outcome | 2013 |
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Etanercept; Female; Health Status; Humans; Hydroxychloroquine; Immunoglobulin G; Joints; Male; Methotrexate; Middle Aged; Prognosis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome | 2013 |
A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Disease Progression; Drug Therapy, Combination; Early Medical Intervention; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Radiography; Remission Induction; Single-Blind Method; Sulfasalazine; Treatment Outcome | 2014 |
Therapies for active rheumatoid arthritis after methotrexate failure.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Failure | 2013 |
Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Intention to Treat Analysis; Male; Methotrexate; Middle Aged; Pensions; Sick Leave; Sulfasalazine; Sweden; Treatment Outcome; Young Adult | 2013 |
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Docosahexaenoic Acids; Double-Blind Method; Drug Therapy, Combination; Early Medical Intervention; Eicosapentaenoic Acid; Female; Fish Oils; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Remission Induction; Sulfasalazine; Treatment Outcome | 2015 |
Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
Topics: Absorptiometry, Photon; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density; Disease Progression; Female; Humans; Hydroxychloroquine; Male; Metacarpal Bones; Methotrexate; Middle Aged; Prednisone; Sulfasalazine | 2015 |
Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Early Diagnosis; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Pain Measurement; Patient Satisfaction; Prednisone; Quality of Life; Range of Motion, Articular; Recovery of Function; Remission Induction; Severity of Illness Index; Single-Blind Method; Sulfasalazine; Time Factors; Treatment Outcome | 2013 |
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Radiography; Smoking; Sulfasalazine; Treatment Outcome | 2015 |
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Health Services; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Quality-Adjusted Life Years; Sick Leave; Sulfasalazine; Treatment Failure; Treatment Outcome | 2015 |
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Injections, Intramuscular; Longitudinal Studies; Male; Methotrexate; Middle Aged; Radiography; Single-Blind Method; Sulfasalazine; Treatment Outcome | 2014 |
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Topics: Adipokines; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Chitinase-3-Like Protein 1; Disease Progression; Drug Therapy, Combination; Epidermal Growth Factor; Female; Foot Joints; Hand Joints; Humans; Hydroxychloroquine; Infliximab; Interleukin-6; Lectins; Leptin; Logistic Models; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Methotrexate; Multivariate Analysis; Prognosis; Radiography; Receptors, Tumor Necrosis Factor, Type I; Resistin; Serum Amyloid A Protein; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2015 |
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Certolizumab Pegol; Cholesterol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Lipid Metabolism; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
Topics: Antibody Specificity; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Disease Progression; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Phosphopyruvate Hydratase; Radiography; Sulfasalazine; Sweden; Vimentin | 2016 |
Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial.
Topics: Adult; Aged; Arthritis, Rheumatoid; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Longitudinal Studies; Male; Methotrexate; Middle Aged; Radiography; Severity of Illness Index; Sulfasalazine; Sweden; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Finland; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Multivariate Analysis; Practice Patterns, Physicians'; Prednisolone; Remission Induction; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Early Diagnosis; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Remission Induction; Severity of Illness Index; Single-Blind Method; Sulfasalazine; Time Factors; Treatment Outcome | 2016 |
Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Sick Leave; Sulfasalazine; Sweden; Time Factors; Treatment Outcome | 2016 |
Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Factors; Cohort Studies; Cost-Benefit Analysis; Drug Therapy, Combination; Etanercept; Female; Health Care Costs; Humans; Hydroxychloroquine; Male; Markov Chains; Methotrexate; Middle Aged; Quality-Adjusted Life Years; Sulfasalazine; Time Factors | 2016 |
Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Lipoproteins, HDL; Male; Methotrexate; Middle Aged; Sulfasalazine | 2017 |
Rheumatoid arthritis triple therapy compared with etanercept: difference in infectious and gastrointestinal adverse events.
Topics: Abscess; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Gastritis; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Ileus; Incidence; Infections; Intestinal Obstruction; Linear Models; Male; Methotrexate; Middle Aged; Pancreatitis; Pneumonia; Respiratory Tract Infections; Sulfasalazine; Urinary Tract Infections | 2017 |
Rheumatoid Arthritis Treatment After Methotrexate: The Durability of Triple Therapy Versus Etanercept.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Canada; Disability Evaluation; Double-Blind Method; Drug Substitution; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Remission Induction; Sulfasalazine; Time Factors; Treatment Outcome; United States; Young Adult | 2017 |
Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bifidobacterium bifidum; Dietary Supplements; Double-Blind Method; Female; Humans; Hydroxychloroquine; Lacticaseibacillus casei; Lactobacillus acidophilus; Male; Methotrexate; Middle Aged; Prednisolone; Synbiotics | 2017 |
Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Joints; Male; Methotrexate; Middle Aged; Prednisone; Radiography; Remission Induction; Severity of Illness Index; Single-Blind Method; Sulfasalazine; Time Factors; Treatment Outcome | 2018 |
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prognosis; Remission Induction; Severity of Illness Index; Treatment Outcome | 2018 |
Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Injections, Subcutaneous; Leflunomide; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome | 2019 |
An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Deprescriptions; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Middle Aged; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
Topics: Adult; Anti-Citrullinated Protein Antibodies; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Male; Methotrexate; Middle Aged; Prognosis; Rheumatoid Factor; Sulfasalazine; Surveys and Questionnaires; Treatment Outcome | 2019 |
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Topics: Adult; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; Humans; Hydroxychloroquine; Janus Kinase Inhibitors; Magnetic Resonance Imaging; Male; Mesalamine; Methotrexate; Middle Aged; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2019 |
Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Quality of Life; Sulfasalazine; Surveys and Questionnaires; Treatment Outcome | 2019 |
Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis: A single-center, randomized, double-blind clinical trial.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Quality of Life; Severity of Illness Index | 2020 |
Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies | 2020 |
Vitamin D: does it help Tregs in active rheumatoid arthritis patients.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; T-Lymphocytes, Regulatory | 2020 |
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Topics: Abatacept; Adult; Aged; Anti-Citrullinated Protein Antibodies; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; C-Reactive Protein; Certolizumab Pegol; Denmark; Drug Therapy, Combination; Early Medical Intervention; Female; Finland; Glucocorticoids; Humans; Hydroxychloroquine; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Netherlands; Norway; Prednisolone; Rheumatoid Factor; Severity of Illness Index; Single-Blind Method; Sulfasalazine; Sweden; Treatment Outcome | 2020 |
The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a rand
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Neoplasm Recurrence, Local; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2021 |
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Middle Aged; Radiography; Sulfasalazine; Symptom Flare Up; Ultrasonography | 2021 |
Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Sulfasalazine; Treatment Outcome | 2022 |
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Infliximab; Methotrexate; Sulfasalazine; Treatment Outcome | 2022 |
225 other study(ies) available for hydroxychloroquine and methotrexate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
Topics: Age Factors; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Gold; Humans; Hydroxychloroquine; Long-Term Care; Methotrexate; Middle Aged; Penicillamine; Prednisone; Private Practice | 1992 |
Drug therapy in the rheumatic diseases.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Gold; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Osteoarthritis; Penicillamine; Rheumatic Diseases | 1992 |
Drugs for rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Azathioprine; Costs and Cost Analysis; Drugs, Investigational; Humans; Hydroxychloroquine; Methotrexate; Monitoring, Physiologic; Organogold Compounds; Penicillamine; Sulfasalazine | 1991 |
[Tryptophan-induced fasciitis-scleroderma-eosinophilia syndrome].
Topics: Aged; Creatine Kinase; Diagnosis, Differential; Eosinophilia; Fasciitis; Female; Fructose-Bisphosphate Aldolase; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Scleroderma, Systemic; Skin; Syndrome; Time Factors; Tryptophan | 1991 |
Effect of medication on synovial fluid leukocyte differentials in patients with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Gold; Humans; Hydroxychloroquine; Leukocytes; Male; Methotrexate; Synovial Fluid | 1991 |
Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Penicillamine; Prognosis; Prospective Studies; Regression Analysis; Time Factors | 1990 |
Drugs for rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Salicylates; Sulfasalazine | 1989 |
Intractable RA--treatment with combined methotrexate, azathioprine and hydroxychloroquine.
Topics: Adult; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Methotrexate; Middle Aged | 1989 |
Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Sulfasalazine | 1987 |
Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Cyclophosphamide; Gold; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Penicillamine | 1985 |
[Therapy of Weber-Christian disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites; Bed Rest; Clindamycin; Colitis; Cyclophosphamide; Humans; Hydroxychloroquine; Methotrexate; Panniculitis, Nodular Nonsuppurative | 1985 |
Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
Topics: Antibodies, Antinuclear; Autoantibodies; Chloroquine; DNA; Erythema; Humans; Hydralazine; Hydroxychloroquine; Injections, Intradermal; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Prednisone; Protein Binding; Skin Manifestations; Ultraviolet Rays | 1967 |
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
Topics: Adenocarcinoma; Adolescent; Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Uterine Neoplasms | 1984 |
Methotrexate in idiopathic granulomatous hepatitis.
Topics: Drug Therapy, Combination; Glucocorticoids; Granuloma; Hepatitis; Humans; Hydroxychloroquine; Methotrexate | 1995 |
Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
Topics: Adenosine Triphosphate; Adult; Azathioprine; Dermatomyositis; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Magnetic Resonance Spectroscopy; Methotrexate; Muscle Contraction; Muscle, Skeletal; Phosphates; Phosphocreatine; Phosphorus Isotopes; Prednisone | 1995 |
The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Boston; Decision Trees; Diagnosis-Related Groups; Drug Costs; Drug Monitoring; Gold; Health Care Costs; Hospitals, University; Humans; Hydroxychloroquine; Massachusetts; Methotrexate; Models, Economic; New Hampshire; Penicillamine; Sensitivity and Specificity | 1995 |
Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Prednisone; Probability | 1993 |
Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prospective Studies; Rheumatic Nodule; Vasculitis | 1993 |
Inverting the therapeutic pyramid: observations and recommendations on new directions in rheumatoid arthritis therapy based on the author's experience.
Topics: Adult; Aged; Arthritis, Rheumatoid; Auranofin; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Severity of Illness Index; Time Factors | 1993 |
Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prognosis; Severity of Illness Index | 1993 |
Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate; Rheumatoid Nodule | 1993 |
What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Practice Patterns, Physicians'; Prednisone; Rheumatology | 1995 |
Accelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis.
Topics: Adolescent; Arthritis, Juvenile; Female; Humans; Hydroxychloroquine; Methotrexate; Rheumatoid Factor; Rheumatoid Nodule | 1996 |
Pustular psoriasis induced by hydroxychloroquine: a case report and review of the literature.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Methotrexate; Psoriasis | 1996 |
Treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Remission Induction; Sulfasalazine | 1996 |
Treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Placebos; Sulfasalazine | 1996 |
Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Disability Evaluation; Drug Administration Schedule; Female; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Pain Measurement; Penicillamine; Prednisone; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 1997 |
Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Organogold Compounds; Pilot Projects; Prospective Studies | 1994 |
Severe multicentric reticulohistiocytosis: disease stabilization achieved with methotrexate and hydroxychloroquine.
Topics: Arthritis; Erythema; Female; Fingers; Histiocytosis; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Radiography | 1997 |
Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prednisone; Retrospective Studies; Rheumatology | 1997 |
A retrospective study of treating RA patients with various combinations of slow-acting antirheumatic drugs in a county hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Drug Therapy, Combination; Gold; Hospitals, County; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine | 1997 |
Estimates of the discriminant ability of definitions of improvement for juvenile rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Auranofin; Discriminant Analysis; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 1998 |
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments.
Topics: Adult; Aged; Alleles; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Administration Schedule; Drug Therapy, Combination; Epitopes; Female; Histocompatibility Testing; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Patient Selection; Sulfasalazine; Treatment Outcome | 1998 |
Urinary neopterin excretion and dihydropteridine reductase activity in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Dihydropteridine Reductase; Female; Gold Compounds; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Neopterin; Rheumatoid Factor; Sulfasalazine | 1998 |
Combination therapy in rheumatoid arthritis: a comment.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1999 |
Methotrexate nodulosis.
Topics: Arm; Biopsy; Dermatologic Agents; Dermatomyositis; Female; Histocytochemistry; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Panniculitis | 1999 |
Treatment considerations in early rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Patient Selection; Risk; Sulfasalazine; Time Factors; Treatment Outcome | 1997 |
Airway obstruction in bronchial sarcoidosis: outcome with treatment.
Topics: Administration, Oral; Adult; Airway Obstruction; Antirheumatic Agents; Biopsy; Bronchial Diseases; Bronchoscopy; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Methylprednisolone; Middle Aged; Radiography, Thoracic; Respiratory Function Tests; Retrospective Studies; Sarcoidosis, Pulmonary; Treatment Outcome | 1999 |
The changing face of rheumatoid arthritis therapy: results of serial surveys.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Data Collection; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine | 2000 |
Drugs for rheumatoid arthritis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anorexia; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Central Nervous System Diseases; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Nausea; Osteoporosis; Plasmapheresis; Prednisone; Sulfasalazine; Tumor Necrosis Factor-alpha | 2000 |
[Psychological and behavioral disorders with good outcome in neurosarcoidosis].
Topics: Adult; Antirheumatic Agents; Cognition Disorders; Drug Therapy, Combination; Facial Paralysis; Female; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Meningitis; Methotrexate; Nervous System Diseases; Neurocognitive Disorders; Paranoid Disorders; Prednisolone; Prognosis; Sarcoidosis; Treatment Outcome | 2001 |
Management of a patient with sarcoid calcaneitis and dactylitis.
Topics: Adult; Antirheumatic Agents; Calcaneus; Drug Therapy, Combination; Finger Joint; Glucocorticoids; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Male; Methotrexate; Sarcoidosis | 2001 |
Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction.
Topics: Alkaloids; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Benzylisoquinolines; Caspase 3; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Death; Cysteine Proteinase Inhibitors; DNA Damage; Drugs, Chinese Herbal; Enzyme Activation; Enzyme Induction; Fas Ligand Protein; fas Receptor; Humans; Hydroxychloroquine; Immunity, Innate; Jurkat Cells; Lymphocyte Activation; Lymphocyte Count; Membrane Glycoproteins; Methotrexate; Signal Transduction; T-Lymphocyte Subsets; Tripterygium; U937 Cells | 2001 |
Conventional DMARD options for patients with a suboptimal response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
[Lymphedema of the upper limb, a complication of rheumatoid polyarthritis].
Topics: Antirheumatic Agents; Arm; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lymphedema; Methotrexate; Middle Aged; Prednisone | 2001 |
Leflunomide for the treatment of systemic lupus erythematosus: comment on the article by McMurray.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Middle Aged; Prednisolone | 2001 |
Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France).
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Drug Therapy, Combination; Female; France; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Organogold Compounds; Rheumatology; Treatment Outcome | 2002 |
Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Drug Combinations; Female; Glucosamine; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Organogold Compounds; Retrospective Studies; Sulfasalazine; Treatment Outcome | 2002 |
Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Costs and Cost Analysis; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Pilot Projects; Practice Patterns, Physicians'; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Surveys and Questionnaires; Tumor Necrosis Factor-alpha | 2002 |
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Topics: Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Disability Evaluation; Drug Administration Schedule; Health Status; Humans; Hydroxychloroquine; Injections, Intramuscular; Methotrexate; Organogold Compounds; Surveys and Questionnaires; Treatment Outcome | 2002 |
[Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs].
Topics: Adult; Anorexia; Antirheumatic Agents; Arthritis, Rheumatoid; Exanthema; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Nausea; Penicillamine; Phytotherapy; Plant Preparations; Retrospective Studies; Sinomenium; Sulfasalazine | 2002 |
[Diagnosis and treatment of rheumatoid arthritis].
Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporins; Diagnosis, Differential; Exercise Therapy; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Rheumatoid Factor; Sulfasalazine | 2002 |
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors | 2003 |
Methotrexate is the leading DMARD in Finland.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Finland; Humans; Hydroxychloroquine; Insurance, Health; Methotrexate; Rheumatic Diseases; Sulfasalazine | 2003 |
[Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Psoriasis; Time Factors | 2003 |
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Methotrexate; Organogold Compounds | 2003 |
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Clinical Protocols; Cohort Studies; Female; Hand; Health Status; Humans; Hydroxychloroquine; Injections, Intra-Articular; Injections, Intramuscular; Male; Methotrexate; Methylprednisolone; Middle Aged; Rheumatoid Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2003 |
Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Direct Service Costs; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Health Resources; Health Services Research; Humans; Hydroxychloroquine; Male; Managed Care Programs; Methotrexate; Middle Aged; Midwestern United States; New England; Sulfasalazine; Time Factors; Treatment Outcome | 2000 |
Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Availability; Drug Interactions; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Models, Biological | 2003 |
[Methotrexate combined with leflunomide or hydroxychloroquine in the treatment of rheumatoid arteritis].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged | 2004 |
Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Folic Acid; Humans; Hydroxychloroquine; Leukemia, Erythroblastic, Acute; Methotrexate; Treatment Outcome | 2005 |
Light chain multiple myeloma in a patient with long-standing rheumatoid arthritis.
Topics: Aged; Antineoplastic Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Compounds; Humans; Hydroxychloroquine; Immunoglobulin Light Chains; Methotrexate; Multiple Myeloma; Pancytopenia; Penicillamine | 2005 |
Hydroxychloroquine does not decrease serum methotrexate concentrations in children with juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Female; Humans; Hydroxychloroquine; Male; Methotrexate | 2005 |
[When to begin rheumatism treatment? Initial combination therapy helps fastest].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
[Symmetric polyarthritis in a patient with Churg-Strauss syndrome].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Recurrence; Sulfasalazine | 2005 |
Twelve years experience of juvenile dermatomyositis in North India.
Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders; Dermatomyositis; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins; India; Lipodystrophy; Male; Medical Records; Methotrexate; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Ulcer | 2006 |
Disseminated cutaneous infection with Mycobacterium chelonae mimicking panniculitis in a patient with dermatomyositis.
Topics: Antineoplastic Agents, Hormonal; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Panniculitis; Prednisolone; Skin | 2005 |
A case of pseudolymphomatous folliculitis.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Folliculitis; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Nose; Pseudolymphoma; Triamcinolone Acetonide | 2006 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Dermatitis herpetiformis and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dapsone; Dermatitis Herpetiformis; Epidermis; Humans; Hydroxychloroquine; Male; Methotrexate; Methylprednisolone; Middle Aged | 2006 |
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Case-Control Studies; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Odds Ratio; Regression Analysis; Risk Factors; Sulfasalazine | 2006 |
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Fatal Outcome; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Inflammation; Methotrexate; Prednisolone | 2006 |
Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
Topics: Adult; Arthralgia; Cyclosporine; Dermatologic Agents; Dermatomyositis; Exanthema; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Prednisone | 2007 |
Leflunomide as adjuvant treatment of dermatomyositis.
Topics: Adjuvants, Immunologic; Adult; Aged; Dermatologic Agents; Dermatomyositis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome | 2008 |
Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Finger Injuries; Fluconazole; Humans; Hydroxychloroquine; Methotrexate; Middle Aged | 2008 |
Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Folic Acid; Gene Frequency; Genotype; Haplotypes; Health Status; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Predictive Value of Tests; Severity of Illness Index; Sulfasalazine; Tetrahydrofolate Dehydrogenase | 2008 |
Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisolone; Retrospective Studies; Sulfasalazine | 2008 |
Enhanced MRI in early undifferentiated oligoarthritis of the knee joints: improvements already visible after 2 months of DMARDs treatment.
Topics: Antirheumatic Agents; Arthritis; Gadolinium; Hydroxychloroquine; Image Enhancement; Knee Joint; Magnetic Resonance Imaging; Methotrexate; Time Factors | 2008 |
Chikungunya virus aches and pains: an emerging challenge.
Topics: Alphavirus Infections; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chikungunya virus; Chronic Disease; Humans; Hydroxychloroquine; Methotrexate; Musculoskeletal Diseases; Sulfasalazine | 2008 |
A 75-year-old man with significant bleeding after transbronchial biopsy.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Bronchi; Hemorrhage; Humans; Hydroxychloroquine; Male; Methotrexate | 2008 |
"Strawberry gums" in sarcoidosis.
Topics: Adult; Antibodies, Monoclonal; Eye Diseases; Female; Gingival Hyperplasia; Humans; Hydroxychloroquine; Infliximab; Methotrexate; Prednisone; Sarcoidosis; Skin Diseases | 2008 |
Disease-modifying antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine | 2009 |
[What's new in internal medicine?].
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Bacteriophages; Body Mass Index; Diabetes Complications; Drug Therapy, Combination; Humans; Hydroxychloroquine; Hypereosinophilic Syndrome; Hypertension; Immunosuppressive Agents; Internal Medicine; Methotrexate; Mimiviridae; Obesity; Risk Factors; Treatment Outcome; Venous Thromboembolism | 2008 |
[Financial cost of early rheumatoid arthritis in the first year of medical attention: three clinical scenarios in a third-tier university hospital in Colombia].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Protocols; Colombia; Diagnostic Services; Direct Service Costs; Disease Management; Drug Costs; Drug Therapy, Combination; Etanercept; Health Care Costs; Hospital Costs; Hospitals, University; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Meloxicam; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Thiazines; Thiazoles | 2009 |
Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Biomarkers; Child; Dapsone; Drug Therapy, Combination; Fat Necrosis; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Hydroxychloroquine; Immunoenzyme Techniques; Immunophenotyping; Male; Methotrexate; Middle Aged; Panniculitis, Lupus Erythematosus; Prednisolone; Retrospective Studies; Skin; T-Lymphocytes; Young Adult | 2010 |
Lipoatrophic panniculitis: case report and review of the literature.
Topics: Ankle; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Child; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lipodystrophy; Magnetic Resonance Imaging; Male; Methotrexate; Panniculitis; Prednisone | 2010 |
Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Hydroxychloroquine; Insulin; Linear Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Treatment Outcome | 2010 |
Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; India; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Time Factors | 2012 |
Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Iran; Logistic Models; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Prednisolone; Prevalence; Risk Assessment | 2011 |
Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Topics: Adult; Aged; Alphavirus Infections; Antirheumatic Agents; Arthritis, Rheumatoid; Chikungunya Fever; Chikungunya virus; Chronic Disease; Drug Therapy, Combination; Epidemics; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Young Adult | 2011 |
The Peters anomaly following antenatal exposure to methotrexate and hydroxychloroquine.
Topics: Anterior Eye Segment; Antirheumatic Agents; Arthritis, Rheumatoid; Corneal Opacity; Enzyme Inhibitors; Eye Abnormalities; Female; Humans; Hydroxychloroquine; Infant, Newborn; Methotrexate; Pregnancy; Prenatal Exposure Delayed Effects | 2011 |
Refractory adult-onset still disease successfully treated with abatacept.
Topics: Abatacept; Adult; Antirheumatic Agents; Humans; Hydroxychloroquine; Immunoconjugates; Male; Methotrexate; Still's Disease, Adult-Onset; Treatment Failure; Treatment Outcome | 2011 |
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Scleroderma, Localized; Synovitis; Treatment Outcome | 2012 |
Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Narcotics; Retrospective Studies; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Still bizarre.
Topics: Abdominal Pain; Adolescent; Arthritis, Juvenile; Bezoars; Drug Therapy, Combination; Humans; Hydroxychloroquine; Ileus; Male; Methotrexate; Prednisone; Proton Pump Inhibitors; Tomography, X-Ray Computed | 2012 |
Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Methotrexate; Withholding Treatment | 2012 |
A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Asian People; Bone Density Conservation Agents; Calcium Compounds; Carcinoma; Dermatomyositis; Dietary Supplements; Diphosphonates; Erythema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nasopharyngeal Neoplasms; Oxides; Prospective Studies; Pruritus; Rituximab; Singapore; Tacrolimus; Tertiary Care Centers; United States; Vitamin D; White People | 2013 |
Dysphonia and dermatomyositis: an unusual manifestation.
Topics: Adult; Antirheumatic Agents; Biopsy; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Dysphonia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Prednisone | 2013 |
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; Dutasteride; Enzyme Inhibitors; Eyebrows; Female; Fibrosis; Forehead; Hospitals, University; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus; Methotrexate; Middle Aged; Minocycline; Osteoporosis, Postmenopausal; Retrospective Studies; Scalp; Tacrolimus; Treatment Outcome | 2013 |
A dancer with rheumatoid arthritis: a role for biologics.
Topics: Arthritis, Rheumatoid; Biological Products; Dancing; Drug Therapy, Combination; Female; Folic Acid; Humans; Hydroxychloroquine; Methotrexate; Treatment Outcome; Young Adult | 2013 |
[Erosive hand osteoarthritis].
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Apatites; Chondroitin Sulfates; Glucocorticoids; Hand; Humans; Hydroxychloroquine; Methotrexate; Osteoarthritis; Prognosis | 2013 |
Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Disability Evaluation; Drug Substitution; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Health Status; Humans; Hydroxychloroquine; Logistic Models; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Failure; Treatment Outcome | 2013 |
Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Isoxazoles; Kaplan-Meier Estimate; Leflunomide; Longitudinal Studies; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2013 |
Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2013 |
Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Failure | 2013 |
Not better but quite good: effects on work loss of combination treatment for rheumatoid arthritis with and without biological agents.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Pensions; Sick Leave; Sulfasalazine | 2013 |
Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs.
Topics: Adult; Aged; Antirheumatic Agents; Anxiety; Arthritis, Rheumatoid; Comorbidity; Depression; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Psychiatric Status Rating Scales; Suicidal Ideation | 2013 |
Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995 through 2010.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement; Female; Finland; Humans; Hydroxychloroquine; Male; Methotrexate; Registries; Sulfasalazine | 2013 |
Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Cohort Studies; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Young Adult | 2013 |
[Rheumatoid arthritis: lower work loss during treatment with biologicals?--Modern treatment principles reduce work loss in rheumatoid arthritis].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Pensions; Sick Leave; Sulfasalazine | 2013 |
Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Periodontitis; Receptors, Tumor Necrosis Factor; Retrospective Studies; Risk Assessment; Risk Factors; Sulfasalazine; Tumor Necrosis Factor-alpha | 2013 |
Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Comorbidity; Female; Glatiramer Acetate; Greece; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Multiple Sclerosis; Natalizumab; Peptides; Prevalence; Rituximab | 2014 |
Generalization and extrapolation of treatment effects from clinical studies in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Feasibility Studies; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Models, Theoretical; Observational Studies as Topic; Pragmatic Clinical Trials as Topic; Treatment Outcome | 2014 |
Rheumatoid arthritis with increased bone mineral density.
Topics: Adult; Arthritis, Rheumatoid; Bone Density; Drug Therapy, Combination; Female; Femur; Hand Bones; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lumbar Vertebrae; Methotrexate; Osteopetrosis; Radiography; Radius; Steroids; Treatment Outcome; Ulna | 2013 |
Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Enzyme Inhibitors; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interferon-gamma Release Tests; Male; Methotrexate; Middle Aged; Mycobacterium tuberculosis; Receptors, Tumor Necrosis Factor; Retrospective Studies; Spondylitis, Ankylosing; Tuberculin Test; Tuberculosis; Tumor Necrosis Factor-alpha | 2014 |
Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.
Topics: Adult; Arthritis; Cohort Studies; Congenital Abnormalities; Female; Fetal Death; Follow-Up Studies; Humans; Hydroxychloroquine; Immune System Diseases; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha | 2014 |
Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients.
Topics: Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; National Health Programs; Retrospective Studies; Sex Factors | 2014 |
Multicentric reticulohistiocytosis can mimic rheumatoid arthritis.
Topics: Alendronate; Arthritis, Rheumatoid; Biopsy, Needle; Diagnosis, Differential; Drug Therapy, Combination; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Hydroxychloroquine; Immunohistochemistry; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome | 2014 |
Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Methylprednisolone; Middle Aged; Severity of Illness Index; Sulfasalazine; Triglycerides; Young Adult | 2013 |
Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study.
Topics: Adult; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Female; Finland; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Registries; Retreatment; Spondylitis, Ankylosing; Treatment Failure; Treatment Outcome | 2014 |
Complete heart block in a case of rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Heart Block; Humans; Hydroxychloroquine; Methotrexate; Pacemaker, Artificial | 2013 |
Osseous sarcoidosis: clinical characteristics, treatment, and outcomes--experience from a large, academic hospital.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Bone and Bones; Bone Diseases; Female; Follow-Up Studies; Hospitals, Teaching; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Sarcoidosis; Treatment Outcome | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Cohort Studies; Cyclosporine; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Incidence; Insurance; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms; Outcome Assessment, Health Care; Proportional Hazards Models; Receptors, Tumor Necrosis Factor; Risk Factors; Taiwan; Tumor Necrosis Factor-alpha | 2014 |
Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes.
Topics: Antirheumatic Agents; Chondrocytes; Dexamethasone; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Enzymologic; Glucocorticoids; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Intramolecular Oxidoreductases; Methotrexate; Osteoarthritis, Knee; Primary Cell Culture; Prostaglandin-E Synthases; Real-Time Polymerase Chain Reaction; Sulfasalazine | 2015 |
A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Bayes Theorem; Data Interpretation, Statistical; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Joints; Male; Methotrexate; Middle Aged; Models, Biological; Predictive Value of Tests; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome; Young Adult | 2015 |
Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cohort Studies; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Employment; Female; Finland; Health Status; Humans; Hydroxychloroquine; Hyperlipidemias; Hypertension; Male; Methotrexate; Middle Aged; Neoplasms; Patient Outcome Assessment; Respiratory Tract Diseases; Sulfasalazine; Tumor Necrosis Factor-alpha | 2015 |
Antiphospholipid antibodies-associated diffuse alveolar hemorrhage.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprine; Biopsy; Cohort Studies; Cyclophosphamide; Female; Hemorrhage; Humans; Hydroxychloroquine; Lung; Lung Diseases; Male; Methotrexate; Middle Aged; Plasma Exchange; Retrospective Studies; Rituximab | 2015 |
Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.
Topics: Adult; Aged; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Autoantibodies; Cohort Studies; Disease Progression; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Proportional Hazards Models; Remission Induction; Sulfasalazine; Time-to-Treatment; Treatment Outcome | 2015 |
Treat-to-target approach in daily clinical practice in Pakistani patients with early Rheumatoid Arthritis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Lost to Follow-Up; Male; Methotrexate; Middle Aged; Remission Induction; Severity of Illness Index; Treatment Outcome | 2015 |
Etanercept in refractory lupus arthritis: An observational study.
Topics: Adult; Antirheumatic Agents; Arthritis; Autoantibodies; Cohort Studies; Etanercept; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Treatment Outcome | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Selective inhibition of extracellular oxidants liberated from human neutrophils--A new mechanism potentially involved in the anti-inflammatory activity of hydroxychloroquine.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arthritis, Experimental; Calcium Signaling; Extracellular Space; Humans; Hydroxychloroquine; In Vitro Techniques; Leukocyte Count; Male; Methotrexate; Middle Aged; NADPH Oxidases; Neutrophils; Oxidants; Phosphorylation; Protein Kinase C; Rats; Rats, Inbred Lew; Respiratory Burst; Young Adult | 2015 |
Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Logistic Models; Male; Medicare Part B; Medication Adherence; Methotrexate; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Sulfasalazine; Time Factors; Treatment Outcome; United States; Young Adult | 2015 |
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.
Topics: Adalimumab; Adult; Aged; Antibodies; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Co-occurrence of rheumatoid arthritis and sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Ankle Joint; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Remission Induction; Sarcoidosis; Tomography, X-Ray Computed; Wrist Joint | 2015 |
Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Sulfasalazine; Treatment Outcome; United States | 2015 |
Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inhibitor of Apoptosis Proteins; Male; Methotrexate; Middle Aged; Proto-Oncogene Mas; Randomized Controlled Trials as Topic; Sulfasalazine; Survivin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Hypercalcemia and Lytic Bone Lesions Masquerading Inflammatory Arthritis Treated as Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Female; Humans; Hydroxychloroquine; Hypercalcemia; Hyperparathyroidism; Methotrexate; Middle Aged; Parathyroidectomy; Rheumatoid Factor | 2015 |
Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication.
Topics: Adult; Anti-Bacterial Agents; Antiphospholipid Syndrome; Ceftazidime; Doxycycline; Femur; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Methotrexate; Osteomyelitis; Prednisone; Salmonella Infections; Sclerosis; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Certolizumab Pegol; Cohort Studies; Cyclophosphamide; Etanercept; Female; Humans; Hydroxychloroquine; Hypertension; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Minocycline; Penicillamine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Chronic Disease; Female; Finland; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Registries | 2016 |
Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Sulfasalazine; Time Factors; United States | 2016 |
Breastfeeding in mothers with systemic lupus erythematosus.
Topics: Adult; Azathioprine; Breast Feeding; Databases, Factual; Decision Making; Female; Humans; Hydroxychloroquine; Infant; Lupus Erythematosus, Systemic; Methotrexate; Milk, Human; Mothers; Prednisolone; Pregnancy; Prospective Studies; Socioeconomic Factors; Young Adult | 2016 |
Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Databases, Factual; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Managed Care Programs; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Young Adult | 2016 |
Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Taiwan; Young Adult | 2016 |
Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Delayed Diagnosis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; India; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome | 2016 |
Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Databases, Factual; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Methotrexate; Middle Aged; Propensity Score; Retrospective Studies; Risk Factors; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; United States; Veterans Health | 2017 |
Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous Dermatomyositis.
Topics: Biopsy, Needle; Dermatomyositis; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Hydroxychloroquine; Immunohistochemistry; Methotrexate; Middle Aged; Stroke; Treatment Outcome | 2016 |
Improving patient-centred care for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Canada; Decision Making; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Methotrexate; Patient Participation; Patient-Centered Care; Quality Improvement; Sulfasalazine | 2016 |
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Australia; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Medication Adherence; Methotrexate; Middle Aged; Remission Induction; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2016 |
Multifocal inflammatory demyelination in a patient with rheumatoid arthritis and treatment complications.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Brain; Demyelinating Diseases; Fatal Outcome; Female; Humans; Hydroxychloroquine; Methotrexate; Middle Aged | 2016 |
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Topics: Abatacept; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Risk Factors; United States | 2017 |
Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients.
Topics: Adult; Antirheumatic Agents; Arthralgia; Case-Control Studies; Female; Follow-Up Studies; Hand; Humans; Hydroxychloroquine; Incidence; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Time Factors; Ultrasonography; Young Adult | 2017 |
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chitinase-3-Like Protein 1; Decision Support Techniques; Drug Therapy, Combination; Epidermal Growth Factor; Female; Humans; Hydroxychloroquine; Infliximab; Interleukin-6; Leptin; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor, Type I; Resistin; Serum Amyloid A Protein; Severity of Illness Index; Sulfasalazine; Treatment Failure; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2017 |
The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoantibodies; CD4-Positive T-Lymphocytes; Complement C3; Complement C4; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Severity of Illness Index; Treatment Outcome; Vaccination; Young Adult | 2016 |
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Topics: Abatacept; Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Case-Control Studies; Etanercept; Female; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Odds Ratio; Risk Factors; Rituximab; Severity of Illness Index; Sulfasalazine; Taiwan; Time Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Psoriasis in systemic lupus erythematosus: a single-center experience.
Topics: Adolescent; Adult; Antirheumatic Agents; Azathioprine; Cohort Studies; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methotrexate; Ontario; Psoriasis; Young Adult | 2017 |
Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cohort Studies; Drug Therapy, Combination; Female; Finland; Glucocorticoids; Humans; Hydroxychloroquine; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Patient Reported Outcome Measures; Remission Induction; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2017 |
Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
CpG-specific methylation at rheumatoid arthritis diagnosis as a marker of treatment response.
Topics: ADAMTS Proteins; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Butyrophilins; CpG Islands; DNA Methylation; Epigenesis, Genetic; Fibroblasts; Humans; Hydroxychloroquine; Joint Capsule; Methotrexate; Sulfasalazine; T-Lymphocytes | 2017 |
Prevalence of glucose intolerance in rheumatoid arthritis patients at a tertiary care centre in Haryana.
Topics: Adult; Arthritis, Rheumatoid; Body Mass Index; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prevalence; Sulfasalazine; Tertiary Care Centers | 2017 |
Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroscopy; Biopsy; Case-Control Studies; Cell Differentiation; Down-Regulation; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lymphocyte Activation; Male; Methotrexate; Middle Aged; Plasma Cells; Principal Component Analysis; Remission Induction; Sequence Analysis, RNA; Sulfasalazine; Synovial Membrane; T-Lymphocytes; Transcriptome | 2017 |
Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chi-Square Distribution; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Kaplan-Meier Estimate; Linear Models; Longitudinal Studies; Male; Medication Adherence; Methotrexate; Middle Aged; Multivariate Analysis; Remission Induction; Risk Factors; Sulfasalazine; Time Factors; Treatment Outcome | 2017 |
A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bayes Theorem; Comparative Effectiveness Research; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Network Meta-Analysis; Patient Preference; Practice Guidelines as Topic; Sulfasalazine; Treatment Outcome | 2018 |
Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfonamides; Treatment Outcome | 2018 |
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Topics: Antirheumatic Agents; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Dermatomyositis; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Models, Statistical; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United Kingdom | 2018 |
Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Female; Humans; Hydroxychloroquine; Incidence; Male; Methotrexate; Middle Aged; Protective Factors; Retrospective Studies; Risk Factors; Stroke; Sulfasalazine; Taiwan; Treatment Outcome | 2018 |
Early macular toxicity following 2 months of hydroxychloroquine therapy.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Macula Lutea; Methotrexate; Middle Aged; Retinal Diseases; Tomography, Optical Coherence | 2018 |
Koebner Phenomenon in Juvenile Dermatomyositis.
Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Creatine Kinase; Dermatologic Agents; Dermatomyositis; Exanthema; Female; Hand Dermatoses; Humans; Hydroxychloroquine; Methotrexate; Muscle Weakness; Prednisone; Pruritus; Remission Induction; Skin; Treatment Outcome | 2018 |
Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Pressure; Female; Humans; Hydroxychloroquine; Hypertension; Incidence; Leflunomide; Linear Models; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2018 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Calcium Channels; Cyclophosphamide; Endothelin Receptor Antagonists; Glucocorticoids; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Kidney Diseases; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Phosphodiesterase 5 Inhibitors; Prostaglandins; Raynaud Disease; Rituximab; Scleroderma, Systemic | 2018 |
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Linear Models; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Sex Factors; Sulfasalazine; Treatment Outcome | 2018 |
The effects of methotrexate and hydroxychloroquine combination therapy vs methotrexate monotherapy in early rheumatoid arthritis patients.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prospective Studies; Regression Analysis; Time Factors; Treatment Outcome | 2019 |
Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Male; Medication Adherence; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2019 |
A lump on the palate.
Topics: Antirheumatic Agents; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Granuloma; Humans; Hydroxychloroquine; Injections, Intralesional; Methotrexate; Middle Aged; Mouth; Palate; Sarcoidosis; Triamcinolone | 2019 |
Commonly used medication for Lupus.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Disease Management; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2018 |
Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prognosis; Protein-Arginine Deiminase Type 4; Sulfasalazine; Treatment Outcome | 2019 |
2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Brazil; Decision Making; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Piperidines; Pyrimidines; Pyrroles; Rheumatology; Societies, Medical; Sulfasalazine | 2018 |
Genetic and epigenetic alteration of the programmed cell death 1 in rheumatoid arthritis.
Topics: Anti-Citrullinated Protein Antibodies; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Odds Ratio; Polymorphism, Single Nucleotide; Programmed Cell Death 1 Receptor; Reverse Transcriptase Polymerase Chain Reaction; Rheumatoid Factor; RNA, Messenger; Sulfasalazine; Transcriptome; Treatment Failure; Treatment Outcome | 2019 |
Erosive rheumatoid arthritis in a young patient with mirror hand.
Topics: Adalimumab; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Glucocorticoids; Hand; Hand Deformities, Congenital; Humans; Hydroxychloroquine; Methotrexate; Polydactyly; Range of Motion, Articular; Treatment Outcome; Ultrasonography | 2019 |
Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Surveys and Questionnaires | 2019 |
Innovative HPTLC method for simultaneous determination of ternary mixture of certain DMARDs in real samples of rheumatoid arthritis patients: an application of quality by design approach.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromatography, Thin Layer; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Sulfasalazine | 2019 |
The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lymphocytes; Male; Methotrexate; Middle Aged; Neutrophils; Prognosis; Sulfasalazine; Treatment Failure | 2019 |
Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts.
Topics: Administration, Oral; Adult; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; France; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Remission Induction; Spain; Treatment Outcome; Young Adult | 2019 |
Osseous sarcoidosis: A multicenter retrospective case-control study of 48 patients.
Topics: Adult; Biopsy, Needle; Bone Diseases; Case-Control Studies; Drug Therapy, Combination; Female; France; Glucocorticoids; Humans; Hydroxychloroquine; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Sarcoidosis; Severity of Illness Index; Treatment Outcome | 2019 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
The impact of different criteria sets on early remission and identifying its predictors in rheumatoid arthritis: results from an observational cohort (2009-2018).
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; China; Cohort Studies; Female; Glucocorticoids; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Patient Reported Outcome Measures; Remission Induction; Retrospective Studies; Sex Factors; Sulfasalazine | 2020 |
Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Diagnosis, Differential; Erythema Multiforme; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Raynaud Disease; Sjogren's Syndrome; Sunlight; Syndrome; Treatment Outcome | 2020 |
Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Topics: 5'-Nucleotidase; Adult; Autoantibodies; Azathioprine; CD8-Positive T-Lymphocytes; Female; Haplotypes; HLA Antigens; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Methotrexate; Muscle, Skeletal; Myositis, Inclusion Body; Prednisolone; Rituximab; Sjogren's Syndrome | 2020 |
Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Brazil; Chi-Square Distribution; Female; Humans; Hydroxychloroquine; Leflunomide; Male; Methotrexate; Middle Aged; Rheumatoid Factor; Statistics, Nonparametric; Sulfasalazine | 2020 |
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cohort Studies; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Scleroderma, Localized; Treatment Outcome; Young Adult | 2020 |
Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Registries; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor Inhibitors; United States | 2021 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Primary Sjogren's syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease.
Topics: Absorptiometry, Photon; Acidosis, Renal Tubular; Adolescent; Antirheumatic Agents; Arthralgia; Bone and Bones; Bone Diseases, Metabolic; Female; Humans; Hydroxychloroquine; Hypokalemia; Immunologic Tests; Methotrexate; Mobility Limitation; Prednisolone; Sjogren's Syndrome; Treatment Outcome; Urinalysis | 2020 |
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Interleukin 1 Receptor Antagonist Protein; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Pandemics; Pneumonia, Viral; Rheumatic Diseases; Rituximab; SARS-CoV-2; Spain; Spondylarthropathies; Tumor Necrosis Factor Inhibitors | 2020 |
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Sulfasalazine; Survival Rate; Treatment Outcome | 2021 |
Clinical features and outcomes from the Singapore Sjögren's syndrome study.
Topics: Adult; Arthralgia; Azathioprine; Female; Humans; Hydroxychloroquine; Keratoconjunctivitis Sicca; Male; Methotrexate; Methylprednisolone; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Singapore; Sjogren's Syndrome; Xerostomia | 2021 |
Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19.
Topics: Anticoagulants; Colchicine; COVID-19 Drug Treatment; Heparin; Humans; Hydroxychloroquine; Methotrexate; Pharmaceutical Preparations; SARS-CoV-2; Venous Thromboembolism | 2021 |
Capillary Blood Levels of Hydroxychloroquine and Methotrexate Are Stable for up to 5 Years When Collected on Volumetric Absorptive Microsamplers.
Topics: Antirheumatic Agents; Chromatography, Liquid; Humans; Hydroxychloroquine; Methotrexate; Tandem Mass Spectrometry | 2021 |
Subacute cutaneous lupus erythematosus triggered after measles vaccination.
Topics: Antirheumatic Agents; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Measles; Methotrexate; Middle Aged; Prednisone; Vaccination; Vitamin B Complex | 2021 |
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Interleukin-12; Interleukin-23; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Phenotype; Prospective Studies; Quinacrine; Referral and Consultation; Remission Induction; Sarcoidosis; Skin Diseases; Tertiary Care Centers; Tumor Necrosis Factor Inhibitors; Young Adult | 2021 |
Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Canada; Child; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; United States; United States Food and Drug Administration; Young Adult | 2021 |
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Chloroquine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Odds Ratio; Registries; Sulfasalazine; Sweden; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2021 |
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Synergism; Drug Therapy, Combination; Erythrocyte Indices; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies | 2022 |
Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results.
Topics: Arthritis, Rheumatoid; Humans; Hydroxychloroquine; Joints; Methotrexate; Quality of Life | 2021 |
The effects of iguratimod combined with methotrexate and hydroxychloroquine on bone mineral density in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bone Density; Chromones; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Retrospective Studies; Sulfonamides | 2021 |
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study.
Topics: Aged; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Hydroxychloroquine; Incidence; Male; Medicare; Methotrexate; Propensity Score; Pulmonary Embolism; Risk Factors; United States; Venous Thromboembolism | 2021 |
Infections in systemic autoimmune diseases.
Topics: Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Sjogren's Syndrome | 2021 |
Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Humans; Hydroxychloroquine; Melanoma; Melanoma, Cutaneous Malignant; Methotrexate; Skin Neoplasms | 2023 |
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors | 2022 |
Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus.
Topics: Adolescent; Antirheumatic Agents; Child; Child, Preschool; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; United States | 2022 |
Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Heart Disease Risk Factors; Humans; Hydroxychloroquine; Medicare; Methotrexate; Myocardial Infarction; Risk Factors; United States | 2022 |
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
Topics: Adrenal Cortex Hormones; Ambulatory Care Facilities; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Azathioprine; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Retrospective Studies; Rheumatic Diseases; Rheumatology; Sarcoidosis | 2022 |
Hydroxychloroquine and Risk of Long QT Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study With Nineteen-Year Follow-up.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Methotrexate; Middle Aged; Retrospective Studies; Veterans | 2023 |
A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Topics: Diagnosis, Differential; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Pseudolymphoma; Skin Diseases; Skin Neoplasms | 2022 |
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases.
Topics: Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; Hydroxychloroquine; Immunogenicity, Vaccine; Immunoglobulin G; Lupus Erythematosus, Systemic; Methotrexate; Rheumatic Diseases; Rheumatic Fever; Rituximab | 2022 |
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset.
Topics: Azathioprine; Communicable Disease Control; COVID-19; Drug Prescriptions; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Pandemics; Sulfasalazine; Time Factors | 2022 |
Childhood-onset rheumatoid arthritis at a tertiary hospital in Senegal, West Africa.
Topics: Adolescent; Adult; Africa, Western; Arthritis, Juvenile; Arthritis, Rheumatoid; Child; Cohort Studies; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Prednisone; Rheumatoid Factor; Senegal; Tertiary Care Centers | 2023 |
Association of patient copayment and medication adherence in systemic lupus erythematosus.
Topics: Adult; Aged; Azathioprine; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2023 |
Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Topics: Arthritis; Dermatitis; Granuloma; Humans; Hydroxychloroquine; Infant; Male; Methotrexate; Mutation; Nod2 Signaling Adaptor Protein; Pruritus; Uveitis | 2023 |
Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease.
Topics: Aged; Cohort Studies; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Ontario; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |